WO2017064923A1 - System for defending against infection, and antimicrobial agent - Google Patents

System for defending against infection, and antimicrobial agent Download PDF

Info

Publication number
WO2017064923A1
WO2017064923A1 PCT/JP2016/074303 JP2016074303W WO2017064923A1 WO 2017064923 A1 WO2017064923 A1 WO 2017064923A1 JP 2016074303 W JP2016074303 W JP 2016074303W WO 2017064923 A1 WO2017064923 A1 WO 2017064923A1
Authority
WO
WIPO (PCT)
Prior art keywords
columnar
antibacterial agent
sprayer
compressor
user
Prior art date
Application number
PCT/JP2016/074303
Other languages
French (fr)
Japanese (ja)
Inventor
吉晴 増井
阿津子 富田
Original Assignee
吉晴 増井
阿津子 富田
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 吉晴 増井, 阿津子 富田 filed Critical 吉晴 増井
Publication of WO2017064923A1 publication Critical patent/WO2017064923A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/20Fabaceae or Leguminosae [Pea or Legume family], e.g. pea, lentil, soybean, clover, acacia, honey locust, derris or millettia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/22Phase substances, e.g. smokes, aerosols or sprayed or atomised substances

Definitions

  • the present invention relates to an antibacterial agent mainly composed of amino acids extracted from cereals, and an infectious disease prevention system sprayed with the antibacterial agent.
  • norovirus In recent years, we hear news such as norovirus outbreaks and spreads every year. In fact, the infectivity of norovirus is very strong, and even a very small number of individuals (10 to 100) can infect humans. Norovirus is said to be resistant to dryness and airborne infection (spray nucleus infection), and it is decisively different from food poisoning symptoms caused by other pathogens in that the virus spreads from person to person and is secondarily infected. For this reason, it is difficult to prevent the spread of infection by norovirus in the same way as general food poisoning countermeasures.
  • Norovirus also has considerable heat resistance, and is not inactivated at 60 ° C, but is finally inactivated by heating at a high temperature of 85 ° C or higher for 1 minute. Norovirus is also highly resistant to disinfectants and will not be inactivated unless it is a high concentration (500 to 1,000 ppm) chlorinated solvent.
  • a further characteristic of the virus is that it does not grow in foods but “grows only in the human intestinal tract”. After the infected person recovers from the disease (norovirus infection), norovirus is discharged in the feces for more than 2 weeks. In addition, the virus is also discharged together with stool for those who have an innocuous infection with norovirus (infected individuals who are infected with norovirus but have no obvious manifestation of infection).
  • a person who handles food for example, an employee who cooks in a kitchen like a school lunch center
  • a person who does not seem to be indistinguishable from an uninfected person the person in charge of the other kitchen
  • the risk of being contaminated with virus in food and tableware is increased due to the virus contamination VP adhering to the employee without knowing it, and the infection easily spreads on the scale of hundreds.
  • it is a norovirus adhering to food it can be said that the defense can be easily done by heating for 1 minute at a temperature of 85 ° C. or higher. Rather, it seems that it is more difficult to prevent infections caused by contaminants on the body and clothes of the person who handles foods because they cannot be protected by simple measures such as hand washing.
  • Patent Document 1 In order to stop the spread of this kind of infectious disease, various technical developments for disinfecting the human body have been attempted (see, for example, Patent Document 1). Furthermore, although it is not a technique for direct disinfection of the human body, a disinfecting and deodorizing device (Patent Document 2) that sprays an atomized disinfectant solution into a person's living space, disinfecting footwear that is an article frequently used by people A disinfection device has been devised for the purpose of preventing the spread of infectious diseases when applied (see Patent Document 3).
  • the spraying device of Patent Document 2 is designed to atomize the sterilizing and deodorizing liquid and spray it in the air so that it can effectively eliminate sterilization and deodorization of the living space and suppress the occurrence of defects such as metal corrosion.
  • the ventilation fan is often operated for the purpose of deodorization in the toilet. Therefore, when the spraying device of the literature 2 is used in the toilet, the mist-like disinfectant sprayed in the toilet space is discharged (ventilated) from the room, and the sterilization and deodorizing effect may be diminished. is assumed.
  • Patent Document 3 is a technique that focuses on “disinfecting footwear” as disclosed in Reference 3 and FIG. Therefore, even if this device configuration is directly applied to norovirus infection countermeasures (human body disinfection), the feet (foot and trouser hems) are firmly disinfected, but the hands and outer cuffs are not disinfected. It is difficult to obtain an appropriate infection prevention effect when the user leaves the toilet. Furthermore, since the article 3 assumes articles (footwear) that do not move around spontaneously as disinfection targets, the photoelectric switch is automatically turned on when the user enters the room, and the footwear is disinfected. Employees are sterilized by manually turning on the switch.
  • the present invention has been made in view of the above-mentioned problems, and “when a user of a facility / equipment (especially a toilet) shared by a large number of people leaves the facility” is caused by a norovirus or the like.
  • the purpose is to prevent.
  • the infection prevention system is: Two or more columnar sprayers are placed upright at both ends of the straight line or at each vertex of the polygonal region, and the surface with the injection holes of the columnar sprayer is set at the midpoint of the straight line or the center of gravity of the polygonal region
  • An infectious disease prevention system that disinfects the human body by spraying antibacterial agents containing amino acids extracted from cereals simultaneously from the spray holes of each columnar sprayer, A liquid tank for storing the antibacterial agent; A rod-shaped hollow straw that holds the discharge port outside the liquid tank and is inserted into the liquid tank so that the suction port is immersed in the antibacterial agent; A compressor that compresses air taken from outside and injects it from an air nozzle; A mist generation chamber in which a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, and a floating droplet nozzle that discharges the antibacterial agent suspended in a mist form in the closed space, is
  • the antibacterial agent injection direction (direction of the surface having the injection holes 62) of each columnar sprayer 6 is all directed to the midpoint M of the straight line and the center of gravity G of the polygonal region, and the foot type
  • the switch 7 is installed near the center of gravity G (see FIGS. 8A, 8B, and 8C).
  • the infectious disease prevention system which concerns on 2nd invention of this application is Two or more columnar sprayers are placed upright at both ends of the straight line or at each vertex of the polygonal region, and the surface with the injection holes of the columnar sprayer is set at the midpoint of the straight line or the center of gravity of the polygonal region
  • An infectious disease prevention system that disinfects the human body by spraying antibacterial agents containing amino acids extracted from cereals simultaneously from the spray holes of each columnar sprayer, A liquid tank for storing the antibacterial agent; A rod-shaped hollow straw that holds the discharge port outside the liquid tank and is inserted into the liquid tank so that the suction port is immersed in the antibacterial agent; A compressor that compresses air taken from outside and injects it from an air nozzle; A mist generation chamber in which a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, and a floating droplet nozzle that discharges the antibacterial agent suspended in a mist form in the closed
  • the antibacterial agent When power is supplied to the compressor, The antibacterial agent is sucked up from the liquid straw into the mist generation chamber by the negative pressure generated in the mist generation chamber by the air being jetted from the air nozzle, and the mist-like antibacterial agent is discharged from the floating droplet nozzle. , The antibacterial agent discharged from the floating droplet nozzle is sprayed from the injection hole of the columnar sprayer to the user who operates the foot switch via a guide tube and a guide pipe.
  • the infectious disease prevention system although the system configuration is different from the first invention in that the IC card reader 71 is adopted as a switch (see FIG. 11), the function for spraying the antibacterial agent is the first.
  • the IC card reader 71 is adopted as a switch (see FIG. 11)
  • the function for spraying the antibacterial agent is the first.
  • the infectious disease protection system which concerns on 3rd invention of this application is an infectious disease protection system which concerns on 1st or 2nd invention
  • the columnar sprayer was configured to have a height of 1 m or more when placed upright.
  • the columnar sprayer can be designed to an arbitrary height as long as it is 1 m or more. However, in order to eliminate the discomfort caused by the antibacterial agent PR applied to the face portion or the like, it should be placed below the shoulder or chest. It is desirable to select a numerical value (height) within a range that can be sprayed.
  • the antibacterial agent according to the fourth invention of the present application is: An antibacterial agent comprising amino acids extracted from cereals, An amino acid mixed solution extracted by separating a solid from a grain solution to which a flocculant has been added after heat treatment and filtration treatment, and an amino acid mixed solution containing a soybean extracted amino acid; Purified water and special reducing alkaline ionized water having a pH value of 12, Butylene glycol, A cationic surfactant, A zwitterionic surfactant, A nonionic surfactant, Chelating agents, It was set as the structure containing.
  • the antibacterial agent according to the fourth invention since the virus inactivating effect and the antibacterial effect are significantly recognized (see Table 1 and FIG. 5), the infectious disease caused by the toilet user's excrement (viral contamination) It becomes possible to prevent expansion.
  • the basic manufacturing method of the antibacterial agent PR used in the infection prevention system of the present application is as follows. First, beans (for example, soybeans) are immersed in water, and then beans that have sufficiently absorbed moisture are crushed into a bowl shape. Subsequently, the bean-like bean solution is heated at around 100 ° C. for 10 to 20 minutes, and further at around 80 ° C. for 20 to 60 minutes. Thereafter, this solution is filtered, and water (purified water and special reducing alkali ion water) and a flocculant are added to the liquid obtained by filtration. Then, the antibacterial agent PR can be obtained by heating the solution after the addition at around 100 ° C. for 20 to 60 minutes to separate the solid matter. The final pH value of the antibacterial agent is around pH 6.0 to pH 7.5.
  • Antibacterial agent PR produced according to the above manufacturing method is soybean extracted amino acid / amino acid mixed solution / surfactant (cationic surfactant, zwitterionic surfactant, nonionic surfactant), chelating agent, special reducing property It contains alkaline ionized water (pH 12) / butylene glycol (or alcohol).
  • the compositions characterizing the antibacterial agent PR of the present invention are “butylene glycol” and “special reducing alkaline ionized water”.
  • Butylene glycol originally has a high bactericidal effect, and furthermore, butylene glycol is not toxic to human skin. Therefore, when implementing disinfection (inactivation of viruses, antibacterial / sterilization against bacteria) using the antibacterial agent PR of the present application. “Ensuring user safety” can also be ensured.
  • a colorless transparent and odorless liquid “special reducing alkali ion water” is added to the total amount of the antibacterial agent PR.
  • the alkaline ionized water is not pure water but contains minerals such as sodium and magnesium.
  • This special reducing alkaline ionized water has a pH (power of hydrogen) value of pH (20 ° C.) of 12 to 12.4, indicating “very strong alkalinity”, and the specific gravity (20 ° C.) is 1.002.
  • the surfactant used in the antibacterial agent PR may be a general surfactant as long as it has an antibacterial action.
  • cationic surfactants include benzalkonium chloride that exhibits bactericidal properties by denaturing bacterial cell membrane proteins.
  • zwitterionic surfactants having antibacterial activity include laurylaminopropionic acid, and examples of nonionic surfactants having antibacterial activity include polyoxy-propylene glycol. Due to the high penetrability of the surfactant, the antibacterial agent PR can efficiently penetrate into virus contaminants attached to the human body and clothes.
  • chelating agent added to the antibacterial agent PR which forms a metal ion and a complex ion by coordination bond
  • a general one such as ethylenediaminetetraacetic acid disodium (EDTA2Na) may be used.
  • EDTA2Na ethylenediaminetetraacetic acid disodium
  • the addition of disodium ethylenediaminetetraacetate (EDTA2Na) prevents precipitation of benzalkonium chloride, amino acids and the like, and also prevents their oxidation.
  • Embodiment of this invention is the example which comprised the infectious disease prevention system 1 (refer FIG. 1) which prevents the infectious disease spread of norovirus by spraying an antibacterial agent to a user when leaving a toilet.
  • the infectious disease prevention system 1 (refer FIG. 1) which prevents the infectious disease spread of norovirus by spraying an antibacterial agent to a user when leaving a toilet.
  • the infectious disease prevention system 1 of the present application includes two or more columnar sprayers 6 at “both ends of a straight line” (FIG. 1) or “each vertex of a polygonal area” (see FIGS. 7A and 7B). Place it upright. Further, in the system 1, the surface of the column sprayer 6 with the injection holes 62 is positioned at the midpoint M of the straight line L (FIG. 8A) or the center of gravity G of the polygonal region (FIGS. 8B and 8C). )) And disinfect the human body by simultaneously spraying the antibacterial agent PR containing amino acids extracted from the grains from the injection holes 62 of each columnar sprayer 6 (FIG. 1).
  • This infection prevention system 1 A liquid tank 3 for storing the antibacterial agent PR; It is a rod-shaped hollow straw, and its discharge port 311 (FIG. 2) is held outside the liquid tank 3 and the suction port 312 (FIG. 2) is inserted into the liquid tank 3 so as to be immersed in the antibacterial agent PR.
  • the mist generation chamber 4 is formed in a closed space into which the air nozzle 28 and the discharge port 311 of the liquid straw 31 are inserted, and the floating droplet nozzle 41 for discharging the antibacterial agent PR suspended in the mist state is attached to the space. And comprising.
  • the system 1 (FIG. 2) Two or more columnar sprayers 6 each including a guide pipe 61 having an injection hole 62 therein; A guide tube 5 connecting the floating droplet nozzle 41 of the mist generation chamber 4 and the guide pipe 61 (FIG. 2) inside the sprayer 6;
  • the switch controls power supply to the compressor 2 and includes a foot switch 7 that is turned on when a load is applied by a user's stepping operation and turned off when the load is released.
  • a foot switch 7 placed on the straight line L (FIG. 1) sandwiched between the columnar sprayers 6 or in a polygonal region (FIGS. 7A and 7B) surrounded by the columnar sprayers 6 is provided.
  • the antibacterial agent PR is sucked up from the liquid straw 31 into the mist generation chamber 4 by the negative pressure generated in the mist generation chamber 4 by the air being jetted from the air nozzle 28 (FIG.
  • the infection prevention system 1 of this example includes a compressor 2, a liquid tank 3, a mist generation chamber 4, a guide tube 5, a column sprayer 6, and a foot switch 7.
  • an antibacterial agent PR having an antibacterial action is used for disinfecting virus contaminants attached to a human body or clothes.
  • the antibacterial agent PR has an inhibitory effect on bacteria (antibacterial effect / bactericidal effect) and an inactivating effect on viruses, and is a liquid antibacterial agent containing amino acids sprayed on the human body.
  • the antibacterial agent PR contains as a main component a natural active ingredient derived from “soybean amino acid” which is a kind of vegetable amino acid. A detailed description of the experimental results showing the effect of the antibacterial agent PR will be given later.
  • the liquid tank 3 shown in FIG. 1 is a container that stores the antibacterial agent PR described above.
  • the liquid straw 31 (FIG. 2) is a rod-shaped hollow straw that is inserted into the tank 3 so that the discharge port 311 is held outside the liquid tank 3 and the suction port 312 is immersed in the antibacterial agent PR.
  • the compressor 2 shown in FIG. 1 can use any compressor such as a reciprocating type (reciprocating type) or a swash plate type.
  • the compressor 2 in this example is a reciprocating type in which the piston 23 reciprocates in the cylinder 22 (see FIG. 3), and compresses by changing the volume of the cylinder 22 due to the reciprocating motion of the piston 23.
  • the cylinder 22 of the compressor 2 is provided with a suction valve 25 that opens only inward and a discharge valve 26 that opens only outward.
  • the suction valve 25 When the piston 23 moves in a direction to increase the volume inside the cylinder 22, the suction valve 25 is opened and air is taken into the cylinder 22 from the outside. After the air has been taken in, the air is compressed when the piston 23 moves in a direction to reduce the volume in the cylinder 22, and the compressed air is discharged to the outside of the cylinder 22 by opening the discharge valve 26.
  • the discharge valve 26 since the discharge valve 26 is connected to the air nozzle 28 via the air tube 27, compressed air is injected from the nozzle 28. Thereby, the air compressed by the compressor 2 is sent into the mist generation chamber 4 in which the air nozzle 28 is inserted.
  • the mist generation chamber 4 has a hollow structure having a closed space inside, and the discharge port 311 and the air nozzle 28 of the liquid straw 31 are inserted (FIG. 2). Furthermore, a floating droplet nozzle 41 that discharges the antibacterial agent PR suspended in a mist form in the same closed space is attached to the mist generation chamber 4. The floating droplet nozzle 41 serves to discharge the mist-like antibacterial agent PR floating inside the mist generation chamber 4 (closed space).
  • the antibacterial agent PR sucked up by the liquid straw 31 is diffused in the mist generation state 4 from the discharge port 311 into the mist generation chamber 4. Further, since the compressed air blown from the air nozzle 28 is discharged from the floating droplet nozzle 41 in the mist generation chamber 4, the mist-like antibacterial agent PR is also transferred from the floating droplet nozzle 41 to the outside of the mist generation chamber 4. To discharge.
  • the guide tube 5 connects the floating droplet nozzle 41 attached to the mist generation chamber 4 and the guide pipe 61 stored in the columnar sprayer 6, so that the floating droplet nozzle is connected. 41 and the guide pipe 61 are made to communicate.
  • the columnar sprayer 6 is an apparatus configured to store the guide pipe 61 having the injection hole 62 therein (FIG. 2). Since the size of the norovirus is 27 nm to 37 nm, the nozzle diameter of the injection hole 62 is set to “30 ⁇ m” so that the particle diameter of the sprayed antibacterial agent PR is about 20 ⁇ m to 30 ⁇ m. In this example, the spray time of the antibacterial agent PR is “2 seconds”, and the spray amount of the antibacterial agent PR per one time is “20 ml to 40 ml”.
  • columnar sprayers 6 are installed. These columnar sprayers 6 are installed and used in an upright state. Furthermore, the present system 1 is “devised in the arrangement pattern of the plurality of columnar sprayers 6” so that virus contaminants attached to the human body and clothes of the toilet user can be disinfected accurately and efficiently. .
  • One columnar sprayer 6 is installed at both ends of the straight line L or at each vertex of the polygonal region (FIGS. 8A, 8B, and 8C). Further, the antibacterial agent injection direction (direction of the surface having the injection holes 62) of the columnar sprayer 6 is all “directed toward the midpoint M of the straight line L and the center of gravity G of the polygonal region”.
  • the foot-operated switch 7 is a momentary switch (a system that is turned on only while the button is pressed and a load is applied, and automatically returns to the off state when the button is released from the load).
  • the switch 7 is preferably installed near the midpoint M of the straight line L and the center of gravity G of the polygonal region so that the antibacterial agent PR is efficiently sprayed to the user of the system 1.
  • a circular foot switch 7 is used.
  • the shape of the switch 7 is arbitrary and may be a “rectangular (for example, rectangular) flat plate switch”.
  • the antibacterial agent PR of this example uses soybean extract components as antibacterial components.
  • Soybean contains tryptophan, lysine, methionine, phenylalanine, threonine, valine, leucine, isoleucine, and histidine, which are essential amino acids that cannot be synthesized in the human body among the amino acids necessary for the human body.
  • soybean contains glycine, alanine, cystine, serine, asparagine, aspartic acid, glutamine, glutamic acid, arginine, tyrosine, and proline, which are classified as non-essential amino acids among amino acids necessary for the human body.
  • the TCID 50 (TCID: median Tissue Culture Infectious Dose) in Table 1 above is a unit for measuring the virus infectivity titer, and is 50 when the virus dilution is inoculated into a test tube or the like to which cells have been cultured and attached in advance. % Concentration that infects cells.
  • the unit of the amount of bacteria in Table 1 is “CFU (Colony Forming Unit) / ml”, which represents the number of units capable of forming colonies (the number of bacteria present in 1 ml).
  • this antibacterial agent PR has a significant “inactivation effect on various viruses” including feline calicivirus (substitute for norovirus with similar properties), SARS coronavirus, and influenza virus.
  • Norovirus is a virus that causes non-bacterial acute gastroenteritis.
  • SARS (Severe Acute Respiratory Syndrome) coronavirus is a virus that is a pathogen of severe acute respiratory syndrome. The influenza virus was tested using the H1N1 strain.
  • antibacterial PR has various antibacterial effects on bacteria including S. cerevisiae, Staphylococcus aureus, enterohemorrhagic Escherichia coli O-157, Escherichia coli, Legionella and Salmonella. It was. Furthermore, as can be seen from Table 1, the antibacterial agent PR of this example has been confirmed to have an “antifungal effect” that suppresses the growth of mold.
  • Cereus spores are bacteria that cause food poisoning and are resident bacteria in the intestinal tract.
  • Staphylococcus aureus is a bacterium that is resident in human skin, digestive tract (intestine), etc. and may cause epidermis infection, food poisoning, pneumonia, meningitis, sepsis, and the like.
  • Enterohemorrhagic Escherichia coli O-157 is a bacterium that causes hemorrhagic colitis that is often infected from foods that are not sufficiently heated.
  • E. coli can also be a causative agent of urinary tract infections.
  • Legionella is a facultative intracellular parasitic bacterium that contains many species that cause Legionella disease, including Legionella pneumonia (Military illness).
  • Salmonella is an enteric bacterium that includes typhoid, paratyphoid, or infectious food poisoning.
  • the antibacterial agent PR used in the infectious disease prevention system of this example has a significant virus inactivating effect and antibacterial effect, so that “infectious disease caused by toilet user excretion (viral contamination)” Contributing to the prevention of the spread of
  • Rotting means that organic matter derived from living organisms (particularly, organic matter containing nitrogen such as protein) is decomposed by microorganisms such as bacteria. Needless to say, the excreta gives off unpleasant odors (mainly odors from “ammonia” and “hydrogen sulfide”) due to the formation and decomposition of spoiled amines (indoles, ketones, etc.).
  • the antibacterial agent PR exhibits an excellent deodorizing effect on “ammonia” as shown in FIG. 5A and also on “hydrogen sulfide” as shown in FIG. 5B. This has been confirmed by experiments.
  • the antibacterial agent PR is also effective against “isovaleric acid” (FIG. 5 (c)) and “normal butyric acid” (FIG. 5 (d)), which are representative components of livestock unpleasant odor among lower fatty acids. Excellent deodorant effect.
  • isovaleric acid has a relevance to the human body as a odor of the sole portion, and normal butyric acid has a cause of bad breath.
  • this antibacterial agent PR is not only due to odor components derived from humans, but also to trimethylamine (which is an osmotic pressure regulating component / trimethylamine-N-oxide contained in fish) that is a rotting odor of fish.
  • trimethylamine which is an osmotic pressure regulating component / trimethylamine-N-oxide contained in fish
  • the effectiveness was also shown (refer FIG.5 (e)).
  • Ammonia, hydrogen sulfide, isovaleric acid, normal butyric acid, and trimethylamine used in the experiment are all listed as substances subject to the Odor Control Law.
  • a solution containing active water alone or a mixture of butylene glycol (or 2.7% alcohol) in active water is used as a diluent. Good. By doing in this way, the permeability of the antibacterial agent PR is enhanced, and the virus inactivating effect, the antibacterial effect, and the deodorizing effect can be efficiently exhibited.
  • step S1 movement of the infectious disease prevention system 1 provided with the said structure is demonstrated.
  • the switch 7 is turned on and electric power for operation is supplied to the compressor 2 (step S1).
  • the motor 21 (FIG. 3) of the compressor 2 operates.
  • the suction valve 25 opens inward and external air is taken into the cylinder 22 (step S2 in FIG. 6). ).
  • the discharge valve 26 opens outward to discharge the compressed air to the outside of the cylinder 22.
  • the discharge valve 26 is connected to the air nozzle 28 through the air tube 27 (FIG. 2), compressed air is injected from the nozzle 28 (step S3 in FIG. 6). Then, the air compressed by the compressor 2 is sent into the mist generation chamber 4 in which the air nozzle 28 is inserted.
  • the antibacterial agent PR in the liquid tank 3 is sucked up from the suction port 312 of the straw 31 toward the discharge port 311 by the negative pressure action generated between the air nozzle 28 and the liquid straw 31 (step S4).
  • the sucked-up antibacterial agent PR diffuses in the form of mist (in the form of minute droplets) from the discharge port 311 into the mist generation chamber 4.
  • the compressed air blown from the air nozzle 28 is discharged from the floating droplet nozzle 41. Therefore, the mist-shaped antibacterial agent PR is also discharged from the floating droplet nozzle 41 to the outside of the mist generation chamber 4 together with the compressed air (step S5).
  • the mist-like antibacterial agent PR is sprayed to the user from the injection hole 62 of the columnar sprayer 6 through the guide tube 5 and the guide pipe 61 (step S6).
  • the antibacterial agent PR is also sprayed on footwear such as cuffs, apron / front apron, trouser hem and shoes worn by the user (FIG. 4).
  • footwear such as cuffs, apron / front apron, trouser hem and shoes worn by the user (FIG. 4).
  • the antibacterial agent PR is sprayed from the columnar sprayer 6 disposed so as to surround the foot switch 7 so that the antibacterial agent PR is It penetrates efficiently into the lower body, arms and hands of users who have left the toilet. This makes it possible to “effectively prevent infectious diseases” caused by norovirus and the like when “users of facilities / equipment (especially toilets) shared by many people leave the facility”.
  • each columnar sprayer 6 is all directed toward the center of gravity G of the polygonal region, and the foot switch 7 is preferably installed near the center of gravity G (FIG. 8 ( b), see FIG. 8C).
  • the foot switch 7 is preferably installed near the center of gravity G (FIG. 8 ( b), see FIG. 8C).
  • the overall shape of the columnar sprayer 6 is not limited to a linear shape, and any shape for enhancing the disinfection effect such as an L shape (see FIG. 10) or a U shape may be adopted.
  • Switch system for controlling power supply to the compressor
  • any type of switch as a switch that controls power supply to the compressor 2.
  • the switches that can be turned on and off by the user in a non-contact manner are not limited to the foot switch 7 illustrated in the above embodiment, but an “IC (Integrated Circuit) card reader 71 and a non-contact IC card 72”. It is also possible to adopt (FIG. 11).
  • the IC card reader 71 When power supply control to the compressor 2 is performed using the IC card reader 71, when the user holds the non-contact type IC card 72 close to the IC card reader 71, the IC card reader 71 and the non-contact type are controlled. Short-distance wireless communication is performed between the IC cards 72. When the IC card reader 71 detects the non-contact type IC card 72 by the wireless communication, the IC card reader 71 turns on the switch of the compressor 2.
  • the switch portion is different from the configuration shown in FIG. 1 (the foot switch 7), but the configuration portion for spraying the antibacterial agent PR has the same configuration as FIG. follow it.
  • “employee ID is composed of a non-contact type IC card 72” can be used to identify each employee individually. .
  • “history of whether or not the employee has performed disinfection by the infectious disease prevention system 1A when using the toilet” is converted into electronic data. It is also possible to record. For this reason, it can be expected that employees will be able to further promote thorough awareness of disinfection.
  • the antibacterial active ingredient of the antibacterial agent PR of this example is not limited to amino acids derived from soybeans, but is not virus-free, such as glycine cysteine, which is an amino acid that constitutes a protein component, or glycylglycine in which two molecules of glycine are peptide-bonded. Any plant- or animal-derived amino acid having an activating effect may be employed.
  • the antibacterial agent PR itself is prepared by blending a surfactant with this antibacterial active ingredient.
  • Glycine, cysteine, and glycylglycine also have a strong deodorizing effect, so even if the toilet user is attached with filth (feces or vomit) mixed with norovirus, the odor emitted from these filth Can be suppressed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Abstract

[Problem] To effectively prevent infection in users of a communal facility. [Solution] A system 1 for defending against infection is provided with: a liquid tank 3 that stores an antimicrobial agent; a rod-shaped, hollow liquid straw 31, of which the discharge port is kept outside the liquid tank and the suction port is inserted into the tank 3 so as to be immersed in the antimicrobial agent; a compressor 2 that compresses air sucked from outside and injects the air from an air nozzle; a mist generating chamber 4 that forms a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, wherein a suspended droplet nozzle 41 for discharging the antimicrobial agent, which is suspended in a nebulized form in the closed spaced, is attached to the mist generating chamber 4; at least two columnar nebulizers 6, which internally house a guiding pipe having an opened injection hole 62; a guiding tube 5 that connects the guiding pipe inside the columnar nebulizers to the suspended droplet nozzle of the mist generating chamber; and a foot-operated switch 7 that controls the supply of power to the compressor 2, said foot-operated switch 7 being turned on when a load is applied by a user's foot-stepping operation, and being turned off when the load is released.

Description

感染症防御システムおよび抗菌剤Infectious disease protection system and antibacterial agent
 本発明は、穀物から抽出されたアミノ酸を主成分とする抗菌剤、および、同抗菌剤を噴霧する感染症防御システムに関する。 The present invention relates to an antibacterial agent mainly composed of amino acids extracted from cereals, and an infectious disease prevention system sprayed with the antibacterial agent.
 近年では、毎年のようにノロウイルスの集団感染・感染拡大といったニュースを耳にする。
 実際のところノロウイルスの感染力は非常に強いものであり、ごくごく少ない個体数(10個~100個)でも人に感染を及ぼしかねない。
 ノロウイルスは乾燥に強く空気感染(飛沫核感染)すると言われており、人から人へウイルスが伝播して二次感染する点で他の病原体による食中毒症状と決定的に異なっている。このため一般的な食中毒対策と同様の対応では、ノロウイルスによる感染拡大を防止することは難しい。
In recent years, we hear news such as norovirus outbreaks and spreads every year.
In fact, the infectivity of norovirus is very strong, and even a very small number of individuals (10 to 100) can infect humans.
Norovirus is said to be resistant to dryness and airborne infection (spray nucleus infection), and it is decisively different from food poisoning symptoms caused by other pathogens in that the virus spreads from person to person and is secondarily infected. For this reason, it is difficult to prevent the spread of infection by norovirus in the same way as general food poisoning countermeasures.
 現時点ではノロウイルスに対するこれといった有効なワクチンが存在せず、一度感染した者であっても繰返し感染するという厄介な性質がある。
 またノロウイルスはかなりの耐熱性も備えており、60℃では不活化せず85℃以上の高温下で1分加熱することでようやく不活化する。
 ノロウイルスは消毒剤に対しても強い耐性があり、高濃度(500~1,000ppm)の塩素系溶剤でないと不活化しない。
At present, there is no such effective vaccine against norovirus, and there is a troublesome property that even a person who has been infected once is repeatedly infected.
Norovirus also has considerable heat resistance, and is not inactivated at 60 ° C, but is finally inactivated by heating at a high temperature of 85 ° C or higher for 1 minute.
Norovirus is also highly resistant to disinfectants and will not be inactivated unless it is a high concentration (500 to 1,000 ppm) chlorinated solvent.
 同ウイルスのさらなる特徴としては、食品中では増殖せず「人の腸管内でのみ増殖」することが挙げられる。
 感染者が罹病(ノロウイルス感染症)から回復した後も2週間以上にわたり、糞便に混じってノロウイルスが排出される。
 なおノロウイルスの不顕性感染者(ノロウイルスに感染しているものの明瞭な感染症状が表立って顕れない感染者)についても、やはり糞便とともに同ウイルスが排出される。
A further characteristic of the virus is that it does not grow in foods but “grows only in the human intestinal tract”.
After the infected person recovers from the disease (norovirus infection), norovirus is discharged in the feces for more than 2 weeks.
In addition, the virus is also discharged together with stool for those who have an innocuous infection with norovirus (infected individuals who are infected with norovirus but have no obvious manifestation of infection).
 このようにノロウイルスは感染者の排泄物とともに排出されることから、共用スペースである「トイレの利用時における感染経路」が問題として取り沙汰されている。
 このようなノロウイルスの感染経路を示唆する根拠の1つとしては、水様下痢便を模した疑似排便を使用して「排便時に、どれだけのウイルス汚染物が便器周辺に飛散するか」検証した実験結果(長野県北信保険福祉事務所)がある。
Since norovirus is discharged together with the excrement of the infected person in this way, the “infectious route when using the toilet”, which is a shared space, is considered as a problem.
As one of the grounds for suggesting such an infection route of Norovirus, it was verified by using a pseudo-defecation that mimics watery diarrheal stool. There is an experimental result (Nagano Hokushin Insurance Welfare Office).
 この実験結果によれば、和式便器JTやその周辺(周辺床部・便器後方の壁面)にも大量に疑似排便の飛散物が付着することが確認されている(図12参照)。
 そのため排便を行った本人の人体・衣服だけでなく、それ以降のトイレ利用者の人体・衣服にも飛散物(ウイルス汚染物VP)が付着する可能性がある。
According to the results of this experiment, it has been confirmed that a large amount of pseudo defecation scattered matter also adheres to the Japanese style toilet JT and its surroundings (peripheral floor and rear wall surface) (see FIG. 12).
For this reason, there is a possibility that the scattered matter (virus contamination VP) adheres not only to the human body / clothes of the person who defecates, but also to the human body / clothes of the toilet user after that.
 また同実験結果によれば「排便時に、どれだけのウイルス汚染物が人体・衣服(下半身)に付着するか」についても同時に確認がなされている(図13参照)。
 同図13から看取されるように和式トイレでは、靴などの履物FWやズボンPT(裾部や臀部)などに排泄物(感染者のウイルス汚染物VP)が飛散してウイルス汚染される可能性が高い。
 また和式・洋式トイレともに臀部・腿への排泄物の飛散が下着・ズボン内側のウイルス汚染につながり、更衣によりウイルスが拡散されるおそれもある。
In addition, according to the result of the experiment, “how much viral contaminants adhere to the human body / clothes (lower body) during defecation” has also been confirmed (see FIG. 13).
As can be seen from FIG. 13, in the Japanese style toilet, excrement (virus contamination VP of the infected person) is scattered on the footwear FW such as shoes and the trousers PT (hems and buttocks) to be virus-contaminated. Probability is high.
In both Japanese-style and Western-style toilets, scattering of excrement on the buttocks and thighs can lead to virus contamination in the underwear and pants, and there is a risk that the virus will spread by changing clothes.
 さらに上記実験時においては「排泄物の処理(尻拭)時に、手や上着の袖口にどれだけのウイルス汚染物が付着するか」も確認がなされている(図14参照)。
 同図14に示す実験結果は、トイレットペーパTPのように排泄物を直接払拭するものだけでなく、同ペーパTPを保持する掌PMや衣服CLの袖口にもウイルス汚染物VPが付着することを示唆するものとなった。
 さらにトイレでは水を流すための水洗レバー・ドアノブなど使用者が皆で使用する共用物も多く、ウイルス汚染物の拡散を助長する。
Furthermore, in the above experiment, it was also confirmed that “how much viral contaminants adhere to the cuffs of hands and outerwear when excrement is treated (wiping the bottom)” (see FIG. 14).
The experimental results shown in FIG. 14 indicate that the virus contaminant VP adheres not only to the waste paper directly wiping away like the toilet paper TP, but also to the palm PM holding the paper TP and the cuffs of the clothes CL. It became a suggestion.
In addition, there are many common items that all users use, such as flush levers and doorknobs for running water in the toilets, which helps spread viral contaminants.
 特に食品を扱う者(例えば、給食センターのように厨房で調理を行う従業員)のなかに不感染者と一見して区別がつかない不顕性感染者が紛れ込んでいる場合、他の厨房担当従業員にも知らず知らずのうちにウイルス汚染物VPが付着することで食品中や食器がウイルス汚染される危険性が高くなり、何百人規模で感染が容易に拡大してしまう。
 食品に付着しているノロウイルスであれば85℃以上の温度で1分間加熱することで感染を防ぐことができるぶん防御が簡単ともいえる。むしろ食品を扱う者自身の体や衣服に付いた汚染物による感染の方が手洗いなどの簡単な対処だけでは防御できない分、防ぐことが難しいものと思われる。
In particular, if a person who handles food (for example, an employee who cooks in a kitchen like a school lunch center) contains a person who does not seem to be indistinguishable from an uninfected person, the person in charge of the other kitchen The risk of being contaminated with virus in food and tableware is increased due to the virus contamination VP adhering to the employee without knowing it, and the infection easily spreads on the scale of hundreds.
If it is a norovirus adhering to food, it can be said that the defense can be easily done by heating for 1 minute at a temperature of 85 ° C. or higher. Rather, it seems that it is more difficult to prevent infections caused by contaminants on the body and clothes of the person who handles foods because they cannot be protected by simple measures such as hand washing.
 このような類の感染症の広がりを食い止めるために、人体を消毒するための様々な技術開発が試みられている(例えば、特許文献1参照)。
 さらに人体に対する直接的な消毒を行う技術ではないものの、人の居住空間に霧化した消毒液を散布する除菌消臭装置(特許文献2)、人がちょくちょく使用する物品である履物に消毒を施すことによる感染症の拡大防止を目的とした消毒装置なども考案されている(特許文献3参照)。
In order to stop the spread of this kind of infectious disease, various technical developments for disinfecting the human body have been attempted (see, for example, Patent Document 1).
Furthermore, although it is not a technique for direct disinfection of the human body, a disinfecting and deodorizing device (Patent Document 2) that sprays an atomized disinfectant solution into a person's living space, disinfecting footwear that is an article frequently used by people A disinfection device has been devised for the purpose of preventing the spread of infectious diseases when applied (see Patent Document 3).
特開2015-100454号公報Japanese Patent Laid-Open No. 2015-100454 特開2011-067614号公報JP 2011-0667614 A 特開2005-095528号公報JP 2005-095528 A
 特許文献1の消毒装置によれば足踏ペダルの踏込操作がされたときに、置台の上に載置された消毒液ボトルから消毒液が噴射される。そのため利用者は、消毒液ボトルの頭頂部に手で触れることなく消毒液を噴霧できる。
 しかしながら同文献1の技術では、下半身や足元付近に付着したウイルスに対しては消毒効果がほとんど得られない。
According to the disinfecting apparatus of Patent Document 1, when the foot pedal is depressed, the disinfecting liquid is ejected from the disinfecting liquid bottle placed on the table. Therefore, the user can spray the disinfectant without touching the top of the disinfectant bottle.
However, with the technique of the literature 1, disinfection effect is hardly obtained for viruses attached to the lower body and the vicinity of the feet.
 特許文献2の噴霧装置は除菌消臭液を霧化して空気中に噴霧することで、居住空間の除菌・消臭を効果的に行いつつ金属腐食などの不具合発生も抑制できるように工夫がなされている。
 しかしながらトイレでは一般に消臭を目的として換気扇を作動させていることも多い。そのため同文献2の噴霧装置をトイレで使用した場合、トイレの空間内を散布した霧状の消毒液が室内から排出(換気)されてしまい、せっかくの除菌消臭効果が薄らいでしまうことが想定される。
The spraying device of Patent Document 2 is designed to atomize the sterilizing and deodorizing liquid and spray it in the air so that it can effectively eliminate sterilization and deodorization of the living space and suppress the occurrence of defects such as metal corrosion. Has been made.
However, in general, the ventilation fan is often operated for the purpose of deodorization in the toilet. Therefore, when the spraying device of the literature 2 is used in the toilet, the mist-like disinfectant sprayed in the toilet space is discharged (ventilated) from the room, and the sterilization and deodorizing effect may be diminished. is assumed.
 また特許文献3による技術は同文献3・図2に開示されるように「履物を消毒」することに着目した技術である。
 そのため、この装置構成を直接的にノロウイルスの感染症対策(人体消毒)に適用しても足元ちかく(履物やズボンの裾)はしっかり消毒されるものの、手や上着の袖口に対する消毒は行われず、利用者がトイレから退出するときに適正な感染症防止効果を得ることは難しい。
 さらに同文献3では消毒対象として自発的に動き回ることのない物品(履物)を想定しているため、利用者の入室時に光電スイッチが自動的にオンすることで履物に消毒を施したり、宿泊施設の従業員がスイッチを手動でオンにすることで消毒を施すように構成されている。
 しかしながら、このようなスイッチ制御により人体に消毒を施す場合、利用者がトイレに入室したときに光電スイッチをオンにしても入口部分を短時間でさっと通り過ぎてしまったり、消毒効果が十分発揮される好適な噴霧位置に利用者が都合よく立ってくれないようなケースは現に十分起こりうる。
Further, the technique disclosed in Patent Document 3 is a technique that focuses on “disinfecting footwear” as disclosed in Reference 3 and FIG.
Therefore, even if this device configuration is directly applied to norovirus infection countermeasures (human body disinfection), the feet (foot and trouser hems) are firmly disinfected, but the hands and outer cuffs are not disinfected. It is difficult to obtain an appropriate infection prevention effect when the user leaves the toilet.
Furthermore, since the article 3 assumes articles (footwear) that do not move around spontaneously as disinfection targets, the photoelectric switch is automatically turned on when the user enters the room, and the footwear is disinfected. Employees are sterilized by manually turning on the switch.
However, when the human body is sterilized by such switch control, even if the photoelectric switch is turned on when the user enters the toilet, the entrance portion can be quickly passed or the sterilizing effect can be sufficiently exerted. A case where the user does not conveniently stand at a suitable spray position can actually occur sufficiently.
 本発明は上記の問題に鑑みてなされたものであり「多人数により共用される施設・設備(とりわけトイレ)の使用者が同施設から退出するとき」にノロウイルスなどに起因する「感染症を効果的に防止」することを目的とする。 The present invention has been made in view of the above-mentioned problems, and “when a user of a facility / equipment (especially a toilet) shared by a large number of people leaves the facility” is caused by a norovirus or the like. The purpose is to prevent.
〔第1発明〕
 そこで上記の課題を解決するために本願の第1発明に係る感染症防御システムは、
 直線の両端部または多角形領域の各頂点に2台以上の柱状噴霧器を立てた状態で配置するとともに、同柱状噴霧器の噴射孔のある面を前記直線の中点または前記多角形領域の重心に向けて設置し、穀物から抽出したアミノ酸を含む抗菌剤を各柱状噴霧器の噴射孔から同時に噴霧することで人体を消毒する感染症防御システムであって、
 
 前記抗菌剤を貯留する液体タンクと、
 棒状の中空ストローであって、その排出口を前記液体タンクの外部に保持するとともに吸上口が抗菌剤に浸るよう同液体タンクに差込まれる液体ストローと、
 外部から取込んだ空気を圧縮して空気ノズルから噴射するコンプレッサと、
 前記空気ノズルならびに液体ストローの排出口が差込まれた閉空間を成し、かつ同閉空間に霧状に浮遊した抗菌剤を吐出する浮遊液滴ノズルが取付けられた霧生成室と、
 前記噴射孔の空いた誘導パイプを内部に格納して成る2台以上の前記柱状噴霧器と、
 前記霧生成室の浮遊液滴ノズルと前記柱状噴霧器内部の誘導パイプとを連結する誘導チューブと、
 前記コンプレッサへの電力供給を司るスイッチであって、利用者の踏込操作により荷重がかかるとオンになり同荷重から解放されるとオフになる足踏式スイッチと、
 を備え、
 
 前記柱状噴霧器に挟まれた直線上または柱状噴霧器に囲まれた多角形領域内に置かれた足踏式スイッチが利用者の踏込操作でオンになり、コンプレッサに電力が供給された場合、
 前記空気ノズルから空気が噴射されたことで霧生成室に生じた負圧により、液体ストローから同霧生成室に抗菌剤が吸上げられるとともに霧状の同抗菌剤が浮遊液滴ノズルから吐出され、
 同浮遊液滴ノズルから吐出された抗菌剤が誘導チューブと誘導パイプを介して前記柱状噴霧器の噴射孔から前記足踏式スイッチを操作した利用者に噴霧される構成とした。
[First invention]
Therefore, in order to solve the above problems, the infection prevention system according to the first invention of the present application is:
Two or more columnar sprayers are placed upright at both ends of the straight line or at each vertex of the polygonal region, and the surface with the injection holes of the columnar sprayer is set at the midpoint of the straight line or the center of gravity of the polygonal region An infectious disease prevention system that disinfects the human body by spraying antibacterial agents containing amino acids extracted from cereals simultaneously from the spray holes of each columnar sprayer,

A liquid tank for storing the antibacterial agent;
A rod-shaped hollow straw that holds the discharge port outside the liquid tank and is inserted into the liquid tank so that the suction port is immersed in the antibacterial agent;
A compressor that compresses air taken from outside and injects it from an air nozzle;
A mist generation chamber in which a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, and a floating droplet nozzle that discharges the antibacterial agent suspended in a mist form in the closed space, is attached;
Two or more columnar sprayers configured to house the guide pipe with the injection hole therein;
A guide tube connecting the floating droplet nozzle of the fog generating chamber and a guide pipe inside the columnar sprayer;
A switch for controlling power supply to the compressor, and is a foot switch that is turned on when a load is applied by a user's stepping operation and turned off when released from the load;
With

When a foot switch placed on a straight line sandwiched between the columnar sprayers or in a polygonal region surrounded by the columnar sprayers is turned on by the user's stepping operation and power is supplied to the compressor,
The antibacterial agent is sucked up from the liquid straw into the mist generation chamber by the negative pressure generated in the mist generation chamber by the air being jetted from the air nozzle, and the mist-like antibacterial agent is discharged from the floating droplet nozzle. ,
The antibacterial agent discharged from the floating droplet nozzle is sprayed from the injection hole of the columnar sprayer to the user who operates the foot switch via a guide tube and a guide pipe.
 上述したように特許文献1~3のような既存技術を適用してもトイレからウイルスが持込まれるのをブロックすることは難しい。
 しかしながら本願発明によれば、トイレの利用者が抗菌剤の入った容器などに触れることなく「足踏式スイッチ7を踏む」だけで、トイレの使用時に人体や衣服に付着したノロウイルス汚染物を的確に消毒できる(図4)。
As described above, it is difficult to block the virus from being taken from the toilet even if the existing techniques such as Patent Documents 1 to 3 are applied.
However, according to the present invention, norovirus contaminants attached to the human body and clothes during use of the toilet can be accurately identified simply by “stepping on the foot switch 7” without touching a container or the like containing an antibacterial agent. Can be disinfected (Fig. 4).
 また第1発明によれば、各柱状噴霧器6の抗菌剤噴射方向(噴射孔62のある面の向き)を直線の中点M・多角形領域の重心Gにすべて向けておくとともに、足踏式スイッチ7を重心G付近に設置する(図8(a)、図8(b)、図8(c)参照)。
 このようにすることで足踏式スイッチ7の踏込操作を行うときに利用者が必然的に中点M・重心G付近に位置することになるため、すべての噴霧器6により抗菌剤PRが利用者に集中的に噴霧され、利用者に付着したウイルス汚染物に対する消毒効果の向上が図られる。
Further, according to the first invention, the antibacterial agent injection direction (direction of the surface having the injection holes 62) of each columnar sprayer 6 is all directed to the midpoint M of the straight line and the center of gravity G of the polygonal region, and the foot type The switch 7 is installed near the center of gravity G (see FIGS. 8A, 8B, and 8C).
By doing so, the user is inevitably positioned near the midpoint M and the center of gravity G when the foot switch 7 is depressed, so that the antibacterial agent PR is used by all the sprayers 6 to the user. The sterilization effect on virus contaminants that are sprayed intensively on the user and attached to the user is improved.
〔第2発明〕
 また上記の課題を解決するために本願の第2発明に係る感染症防御システムは、
 直線の両端部または多角形領域の各頂点に2台以上の柱状噴霧器を立てた状態で配置するとともに、同柱状噴霧器の噴射孔のある面を前記直線の中点または前記多角形領域の重心に向けて設置し、穀物から抽出したアミノ酸を含む抗菌剤を各柱状噴霧器の噴射孔から同時に噴霧することで人体を消毒する感染症防御システムであって、
 
 前記抗菌剤を貯留する液体タンクと、
 棒状の中空ストローであって、その排出口を前記液体タンクの外部に保持するとともに吸上口が抗菌剤に浸るよう同液体タンクに差込まれる液体ストローと、
 外部から取込んだ空気を圧縮して空気ノズルから噴射するコンプレッサと、
 前記空気ノズルならびに液体ストローの排出口が差込まれた閉空間を成し、かつ同閉空間に霧状に浮遊した抗菌剤を吐出する浮遊液滴ノズルが取付けられた霧生成室と、
 前記噴射孔の空いた誘導パイプを内部に格納して成る2台以上の前記柱状噴霧器と、
 前記霧生成室の浮遊液滴ノズルと前記柱状噴霧器内部の誘導パイプとを連結する誘導チューブと、
 当該感染症防御システムの利用者が所持する非接触型IC(Integrated Circuit)カードと、
 前記コンプレッサへの電力供給を司る装置であって、利用者によってかざされた非接触型ICカードを検出したときにコンプレッサをオンにするICカードリーダと、
 を備え、
 
 前記柱状噴霧器に挟まれた直線上または柱状噴霧器に囲まれた多角形領域内に置かれたICカードリーダが利用者によりかざされた非接触型ICカードを検出することでコンプレッサのスイッチがオンになり、コンプレッサに電力が供給された場合、
 前記空気ノズルから空気が噴射されたことで霧生成室に生じた負圧により、液体ストローから同霧生成室に抗菌剤が吸上げられるとともに霧状の同抗菌剤が浮遊液滴ノズルから吐出され、
 同浮遊液滴ノズルから吐出された抗菌剤が誘導チューブと誘導パイプを介して前記柱状噴霧器の噴射孔から前記足踏式スイッチを操作した利用者に噴霧される構成とした。
[Second invention]
Moreover, in order to solve said subject, the infectious disease prevention system which concerns on 2nd invention of this application is
Two or more columnar sprayers are placed upright at both ends of the straight line or at each vertex of the polygonal region, and the surface with the injection holes of the columnar sprayer is set at the midpoint of the straight line or the center of gravity of the polygonal region An infectious disease prevention system that disinfects the human body by spraying antibacterial agents containing amino acids extracted from cereals simultaneously from the spray holes of each columnar sprayer,

A liquid tank for storing the antibacterial agent;
A rod-shaped hollow straw that holds the discharge port outside the liquid tank and is inserted into the liquid tank so that the suction port is immersed in the antibacterial agent;
A compressor that compresses air taken from outside and injects it from an air nozzle;
A mist generation chamber in which a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, and a floating droplet nozzle that discharges the antibacterial agent suspended in a mist form in the closed space, is attached;
Two or more columnar sprayers configured to house the guide pipe with the injection hole therein;
A guide tube connecting the floating droplet nozzle of the fog generating chamber and a guide pipe inside the columnar sprayer;
A contactless IC (Integrated Circuit) card possessed by the user of the infectious disease prevention system;
An apparatus that controls power supply to the compressor, and an IC card reader that turns on the compressor when a non-contact IC card held by a user is detected;
With

When the IC card reader placed on a straight line sandwiched between the columnar sprayers or in a polygonal region surrounded by the columnar sprayers detects a non-contact IC card held by the user, the compressor is turned on. When power is supplied to the compressor,
The antibacterial agent is sucked up from the liquid straw into the mist generation chamber by the negative pressure generated in the mist generation chamber by the air being jetted from the air nozzle, and the mist-like antibacterial agent is discharged from the floating droplet nozzle. ,
The antibacterial agent discharged from the floating droplet nozzle is sprayed from the injection hole of the columnar sprayer to the user who operates the foot switch via a guide tube and a guide pipe.
 第2発明に係る感染症防御システムによれば、スイッチとしてICカードリーダ71を採用する点で第1発明とはシステム構成が異なるものの(図11参照)、抗菌剤を噴霧する機能については第1発明と同一の技術的特徴を有することにより「ウイルス汚染物に対して第1発明と同等の消毒効果」を奏することが可能となる。 According to the infectious disease prevention system according to the second invention, although the system configuration is different from the first invention in that the IC card reader 71 is adopted as a switch (see FIG. 11), the function for spraying the antibacterial agent is the first. By having the same technical features as the invention, it is possible to achieve the “disinfection effect equivalent to that of the first invention against virus contaminants”.
〔第3発明〕
 また上記の課題を解決するために本願の第3発明に係る感染症防御システムは、第1または第2発明に係る感染症防御システムであって、
 前記柱状噴霧器は立てて配置したときの高さが1m以上である構成とした。
[Third invention]
Moreover, in order to solve said subject, the infectious disease protection system which concerns on 3rd invention of this application is an infectious disease protection system which concerns on 1st or 2nd invention,
The columnar sprayer was configured to have a height of 1 m or more when placed upright.
 第3発明によれば噴霧器の高さを好適な高さに選定することで、トイレから戻ったときに利用者の腕部や下半身以下に洩れなく消毒できる。
 なお上記柱状噴霧器の高さは1m以上であれば任意の高さに設計可能であるが、顔部分などに抗菌剤PRがかかってしまうことによる不快感をなくすためには、肩ないしは胸部以下に噴霧されるような範囲内で数値(高さ)選択することが望ましい。
According to the third aspect of the invention, by selecting a suitable height of the sprayer, it is possible to sterilize without leaking below the user's arm and lower body when returning from the toilet.
The columnar sprayer can be designed to an arbitrary height as long as it is 1 m or more. However, in order to eliminate the discomfort caused by the antibacterial agent PR applied to the face portion or the like, it should be placed below the shoulder or chest. It is desirable to select a numerical value (height) within a range that can be sprayed.
〔第4発明〕
 上記の課題を解決するために本願の第4発明に係る抗菌剤は、
 穀物から抽出されたアミノ酸をそれぞれに含んで成る抗菌剤であって、
 
 加熱処理ならびに濾過処理がなされた後に凝集剤が添加された穀物の溶液から固形物を分離することで抽出されるアミノ酸混合液であって、大豆抽出アミノ酸を含んだアミノ酸混合液と、
 精製水ならびにpH値が12である特殊還元性アルカリイオン水と、
 ブチレングリコールと、
 陽イオン界面活性剤と、
 両性イオン界面活性剤と、
 非イオン系界面活性剤と、
 キレート剤と、
 を含有する構成とした。
[Fourth Invention]
In order to solve the above problems, the antibacterial agent according to the fourth invention of the present application is:
An antibacterial agent comprising amino acids extracted from cereals,

An amino acid mixed solution extracted by separating a solid from a grain solution to which a flocculant has been added after heat treatment and filtration treatment, and an amino acid mixed solution containing a soybean extracted amino acid;
Purified water and special reducing alkaline ionized water having a pH value of 12,
Butylene glycol,
A cationic surfactant,
A zwitterionic surfactant,
A nonionic surfactant,
Chelating agents,
It was set as the structure containing.
 第4発明に係る抗菌剤によれば、ウイルス不活化効果・抗菌効果が有意に認められるため(表1ならびに図5参照)、トイレ利用者の排泄物(ウイルス汚染物)に起因する感染症の拡大を防止することが可能となる。 According to the antibacterial agent according to the fourth invention, since the virus inactivating effect and the antibacterial effect are significantly recognized (see Table 1 and FIG. 5), the infectious disease caused by the toilet user's excrement (viral contamination) It becomes possible to prevent expansion.
 なお本願の感染症防御システムにおいて使用する抗菌剤PR(図1)の基本製法は、以下の通りである、
 まず豆類(たとえば大豆)を水に浸漬してから、水分を十分に吸収した豆を砕いて粥状にする。続いて粥状にした豆の溶液を100℃付近で10~20分加熱し、さらに80℃付近で20~60分加熱する。
 その後、この溶液を濾過し、濾過で得られた液に水(精製水ならびに特殊還元性アルカリイオン水)と凝集剤を添加する。そして添加後の溶液を100℃付近で20~60分加熱し、固形物を分離することで抗菌剤PRを得ることができる。
 同抗菌剤の最終的なpH値は、pH6.0~pH7.5前後である。
In addition, the basic manufacturing method of the antibacterial agent PR (FIG. 1) used in the infection prevention system of the present application is as follows.
First, beans (for example, soybeans) are immersed in water, and then beans that have sufficiently absorbed moisture are crushed into a bowl shape. Subsequently, the bean-like bean solution is heated at around 100 ° C. for 10 to 20 minutes, and further at around 80 ° C. for 20 to 60 minutes.
Thereafter, this solution is filtered, and water (purified water and special reducing alkali ion water) and a flocculant are added to the liquid obtained by filtration. Then, the antibacterial agent PR can be obtained by heating the solution after the addition at around 100 ° C. for 20 to 60 minutes to separate the solid matter.
The final pH value of the antibacterial agent is around pH 6.0 to pH 7.5.
 上記製法にしたがって生成された抗菌剤PRは、大豆抽出アミノ酸・アミノ酸混合液・界面活性剤(陽イオン界面活性剤、両性イオン界面活性剤、非イオン系界面活性剤)・キレート剤・特殊還元性アルカリイオン水(pH12)・ブチレングリコール(ないしはアルコール)を含むものである。
 これらのうち本発明の抗菌剤PRを特徴づける組成物は「ブチレングリコール」と「特殊還元性アルカリイオン水」である。
Antibacterial agent PR produced according to the above manufacturing method is soybean extracted amino acid / amino acid mixed solution / surfactant (cationic surfactant, zwitterionic surfactant, nonionic surfactant), chelating agent, special reducing property It contains alkaline ionized water (pH 12) / butylene glycol (or alcohol).
Among these, the compositions characterizing the antibacterial agent PR of the present invention are “butylene glycol” and “special reducing alkaline ionized water”.
 ブチレングリコールは元来殺菌効果が高く、さらにブチレングリコールは人間の皮膚に対する毒性がないため、本願の抗菌剤PRを利用して消毒(ウイルスの不活化、細菌に対する抗菌・殺菌)を実施する上で「利用者の安全性についても確保」することができる。 Butylene glycol originally has a high bactericidal effect, and furthermore, butylene glycol is not toxic to human skin. Therefore, when implementing disinfection (inactivation of viruses, antibacterial / sterilization against bacteria) using the antibacterial agent PR of the present application. “Ensuring user safety” can also be ensured.
 また本願発明では抗菌剤PRの全体量に対して、無色透明かつ無臭の液体「特殊還元性アルカリイオン水」を6%程度添加する。同アルカリイオン水は純水ではなく、ナトリウム・マグネシウムなどのミネラル分を含んでいる。
 この特殊還元性アルカリイオン水のpH(power of hydrogen:水素イオン濃度指数)値はpH(20℃)12~12.4であり「非常に強いアルカリ性」を示しており、比重(20℃)は1.002である。
Further, in the present invention, about 6% of a colorless transparent and odorless liquid “special reducing alkali ion water” is added to the total amount of the antibacterial agent PR. The alkaline ionized water is not pure water but contains minerals such as sodium and magnesium.
This special reducing alkaline ionized water has a pH (power of hydrogen) value of pH (20 ° C.) of 12 to 12.4, indicating “very strong alkalinity”, and the specific gravity (20 ° C.) is 1.002.
 このような強アルカリ性の特殊還元性アルカリイオン水は、ノロウイルス・インフルエンザウイルスを不活化できることが実験により確認されている。
 このような効果を奏する特殊還元性アルカリイオン水をトイレ使用後の消毒に応用すれば「トイレ使用者の人体・衣服に付着したウイルス汚染物に潜む各種ウイルスの不活化や細菌の抑制」が可能である。
It has been experimentally confirmed that such strong alkaline special reducing alkaline ionized water can inactivate Norovirus and influenza virus.
If special reducing alkaline ionized water with such effects is applied to disinfection after toilet use, it is possible to "inactivate various viruses hidden in virus contaminants attached to the body and clothes of toilet users and control bacteria" It is.
 なお本抗菌剤PRで使用する界面活性剤は、抗菌作用を有するものであれば一般的な界面活性剤を採用できる。
 その一例として陽イオン界面活性剤には、細菌細胞膜のタンパク質を変性させることによって殺菌性を発揮する塩化ベンザルコニウムが挙げられる。
 また抗菌作用のある両性イオン界面活性剤の例としてラウリルアミノプロピオン酸、さらに抗菌作用のある非イオン系界面活性剤の例としてポリオキシ-プロピレングリコールが挙げられる。
 界面活性剤が有する高い浸透性により、抗菌剤PRが効率よく人体・衣服に付着したウイルス汚染物に浸透できる。
 さらに本抗菌剤PRに添加するキレート剤(配位結合によって金属イオンと錯イオンを形成するもの)についても、エチレンジアミン4酢酸2ナトリウム(EDTA2Na)をはじめとする一般的なものを使用すればよい。
 エチレンジアミン4酢酸2ナトリウム(EDTA2Na)の添加により塩化ベンザルコニウムやアミノ酸などの析出防止が図られるとともに、それらの酸化防止も図られる。
The surfactant used in the antibacterial agent PR may be a general surfactant as long as it has an antibacterial action.
As an example, cationic surfactants include benzalkonium chloride that exhibits bactericidal properties by denaturing bacterial cell membrane proteins.
Examples of zwitterionic surfactants having antibacterial activity include laurylaminopropionic acid, and examples of nonionic surfactants having antibacterial activity include polyoxy-propylene glycol.
Due to the high penetrability of the surfactant, the antibacterial agent PR can efficiently penetrate into virus contaminants attached to the human body and clothes.
Furthermore, as for the chelating agent added to the antibacterial agent PR (which forms a metal ion and a complex ion by coordination bond), a general one such as ethylenediaminetetraacetic acid disodium (EDTA2Na) may be used.
The addition of disodium ethylenediaminetetraacetate (EDTA2Na) prevents precipitation of benzalkonium chloride, amino acids and the like, and also prevents their oxidation.
 なお塩素系消毒液を利用して人体に噴霧消毒を施すと、殺菌作用・抗菌作用だけでなく塩素の漂白効果により利用者が着用している衣類などの布製品が白抜きされてしまうおそれがある。
 しかしながら本願の感染症防御システムで使用する抗菌剤は、染色した繊維製品に噴霧して脱色試験・変色試験を行った結果、脱色・変色の生じないことが確認されている。
 そのため本抗菌剤が本システムの利用者の衣服などに付着しても、脱色(白抜き)を防止できる。
 
In addition, if spray disinfection is performed on the human body using a chlorine-based disinfectant, cloth products such as clothing worn by the user may be whitened not only due to the bactericidal and antibacterial effects but also the bleaching effect of chlorine. is there.
However, the antibacterial agent used in the infectious disease prevention system of the present application has been confirmed to be free from decolorization / discoloration as a result of spraying on a dyed textile product and performing a decoloration / discoloration test.
Therefore, even if the antibacterial agent adheres to clothes of the user of the system, it can prevent decolorization (outlined).
本実施形態の感染症防御システムの全体構成を示す外観模式図である。It is an external appearance schematic diagram which shows the whole structure of the infectious disease prevention system of this embodiment. 感染症防御システムの外観図に想像線を加えた模式図である。It is the schematic diagram which added the imaginary line to the external view of an infectious disease prevention system. シリンダの内部構造を示す断面図である。It is sectional drawing which shows the internal structure of a cylinder. 感染症防御システムにおいて利用者に抗菌剤を噴霧するときの使用状態を示す模式図である。It is a schematic diagram which shows the use condition when spraying an antibacterial agent to a user in an infectious disease prevention system. 経過時間に対する臭気の濃度を示す模式図であって、(a)はアンモニアに対する図、(b)は硫化水素に対する図、(c)はイソ吉草酸に対する図、(d)はノルマル酪酸に対する図、(e)はトリメチルアミンに対する図である。It is a schematic diagram showing the concentration of odor with respect to elapsed time, (a) is a diagram for ammonia, (b) is a diagram for hydrogen sulfide, (c) is a diagram for isovaleric acid, (d) is a diagram for normal butyric acid, (E) is a diagram for trimethylamine. 実施形態に係る感染症防御システムの動作フローを示す図である。It is a figure which shows the operation | movement flow of the infectious disease prevention system which concerns on embodiment. 多角形領域の各頂点に対する柱状噴霧器の配置図であって、(a)は三角形領域における図、(b)は矩形領域における図である。It is the layout of the columnar sprayer with respect to each vertex of a polygonal area | region, Comprising: (a) is a figure in a triangular area | region, (b) is a figure in a rectangular area | region. 柱状噴霧器の噴射孔の向きを示す模式図であって、(a)は直線における図、(b)は三角形領域における図、(c)は矩形領域における図である。It is a schematic diagram which shows the direction of the injection hole of a columnar sprayer, (a) is a figure in a straight line, (b) is a figure in a triangular area | region, (c) is a figure in a rectangular area | region. 隣合う柱状噴霧器の間に板部材を設置して囲いを設けたときの模式図であって、(a)は柱状噴霧器3台の配置例、(b)は柱状噴霧器4台の配置例である。It is a schematic diagram when installing a board member between adjacent columnar sprayers and providing an enclosure, (a) is an arrangement example of three columnar sprayers, (b) is an arrangement example of four columnar sprayers. . L字形に形成された柱状噴霧器の配置例を示す模式図である。It is a schematic diagram which shows the example of arrangement | positioning of the columnar sprayer formed in L shape. 柱状噴霧器の動作制御機構としてICカードリーダを採用したときの感染症防御システムの構成を示す模式図である。It is a schematic diagram which shows the structure of the infectious disease prevention system when an IC card reader is employ | adopted as an operation | movement control mechanism of a columnar sprayer. 排便後のトイレにおいて、どれだけの汚染物が便器周辺に飛散するかを検証した実験結果を示す図である。It is a figure which shows the experimental result which verified how much contaminants scattered around the toilet bowl in the toilet after defecation. 排便後のトイレにおいて、どれだけのウイルス汚染物が下半身に飛散するかを検証した実験結果を示す図である。It is a figure which shows the experimental result which verified how much viral contaminants scattered in the lower body in the toilet after defecation. 排泄物の払拭処理後に、どれだけのウイルス汚染物が手や上着の袖口に飛散するかを検証した実験結果を示す図である。It is a figure which shows the experimental result which verified how much viral contaminants scattered in the cuff of a hand or a jacket after the wiping process of excrement.
 以下、図1乃至図14を参照して、本発明の感染症防御システムについて説明する。
[実施形態]
 本発明の実施形態は、トイレから退出する際に利用者に抗菌剤を噴霧することでノロウイルスの感染症拡大を防止する感染症防御システム1(図1参照)を構成した例である。
Hereinafter, the infection prevention system of the present invention will be described with reference to FIGS.
[Embodiment]
Embodiment of this invention is the example which comprised the infectious disease prevention system 1 (refer FIG. 1) which prevents the infectious disease spread of norovirus by spraying an antibacterial agent to a user when leaving a toilet.
 本願の感染症防御システム1は「直線の両端部」(図1)または「多角形領域の各頂点」(図7(a)、図7(b)参照)に2台以上の柱状噴霧器6を立てた状態で配置する。
 さらに同システム1は、柱状噴霧器6の噴射孔62のある面を上記直線Lの中点M(図8(a))または上記多角形領域の重心G(図8(b)・図8(c))に向けて設置し、穀物から抽出したアミノ酸を含む抗菌剤PRを各柱状噴霧器6の噴射孔62から同時に噴霧することで人体を消毒する(図1)。
The infectious disease prevention system 1 of the present application includes two or more columnar sprayers 6 at “both ends of a straight line” (FIG. 1) or “each vertex of a polygonal area” (see FIGS. 7A and 7B). Place it upright.
Further, in the system 1, the surface of the column sprayer 6 with the injection holes 62 is positioned at the midpoint M of the straight line L (FIG. 8A) or the center of gravity G of the polygonal region (FIGS. 8B and 8C). )) And disinfect the human body by simultaneously spraying the antibacterial agent PR containing amino acids extracted from the grains from the injection holes 62 of each columnar sprayer 6 (FIG. 1).
 本感染症防御システム1は、
 抗菌剤PRを貯留する液体タンク3と、
 棒状の中空ストローであって、その排出口311(図2)を液体タンク3の外部に保持するとともに吸上口312(同図2)が抗菌剤PRに浸るよう同液体タンク3に差込まれる液体ストロー31と、
 外部から取込んだ空気を圧縮して空気ノズル28から噴射するコンプレッサ2と、
 空気ノズル28ならびに液体ストロー31の排出口311が差込まれた閉空間を成し、かつ同空間に霧状に浮遊した抗菌剤PRを吐出する浮遊液滴ノズル41が取付けられた霧生成室4と、を備える。
This infection prevention system 1
A liquid tank 3 for storing the antibacterial agent PR;
It is a rod-shaped hollow straw, and its discharge port 311 (FIG. 2) is held outside the liquid tank 3 and the suction port 312 (FIG. 2) is inserted into the liquid tank 3 so as to be immersed in the antibacterial agent PR. A liquid straw 31;
A compressor 2 that compresses air taken from outside and injects it from an air nozzle 28;
The mist generation chamber 4 is formed in a closed space into which the air nozzle 28 and the discharge port 311 of the liquid straw 31 are inserted, and the floating droplet nozzle 41 for discharging the antibacterial agent PR suspended in the mist state is attached to the space. And comprising.
 さらに同システム1(図2)は、
 噴射孔62の空いた誘導パイプ61を内部に格納して成る2台以上の柱状噴霧器6と、
 霧生成室4の浮遊液滴ノズル41と、上記噴霧器6内部の誘導パイプ61(同図2)とを連結する誘導チューブ5と、
 コンプレッサ2への電力供給を司るスイッチであって、利用者の踏込操作により荷重がかかるとオンになり同荷重から解放されるとオフになる足踏式スイッチ7と、を備えている。
Furthermore, the system 1 (FIG. 2)
Two or more columnar sprayers 6 each including a guide pipe 61 having an injection hole 62 therein;
A guide tube 5 connecting the floating droplet nozzle 41 of the mist generation chamber 4 and the guide pipe 61 (FIG. 2) inside the sprayer 6;
The switch controls power supply to the compressor 2 and includes a foot switch 7 that is turned on when a load is applied by a user's stepping operation and turned off when the load is released.
 上記柱状噴霧器6に挟まれた直線L(図1)上または柱状噴霧器6に囲まれた多角形領域(図7(a)・図7(b))内に置かれた足踏式スイッチ7が利用者の踏込操作でオンになり、コンプレッサ2に電力が供給された場合、
 空気ノズル28(図2)から空気が噴射されたことで霧生成室4に生じた負圧により、液体ストロー31から同霧生成室4に抗菌剤PRが吸上げられるとともに霧状の同抗菌剤PRが浮遊液滴ノズル41から吐出され、
 同浮遊液滴ノズル41から吐出された抗菌剤PRが誘導チューブ5と誘導パイプ61を介して柱状噴霧器6の噴射孔62から足踏式スイッチ7を操作した利用者に噴霧されるように構成される。
 以下、この内容について詳しく説明する。
A foot switch 7 placed on the straight line L (FIG. 1) sandwiched between the columnar sprayers 6 or in a polygonal region (FIGS. 7A and 7B) surrounded by the columnar sprayers 6 is provided. When power is supplied to the compressor 2 when turned on by the user's stepping operation,
The antibacterial agent PR is sucked up from the liquid straw 31 into the mist generation chamber 4 by the negative pressure generated in the mist generation chamber 4 by the air being jetted from the air nozzle 28 (FIG. 2), and the mist-like antibacterial agent PR is discharged from the floating droplet nozzle 41,
The antibacterial agent PR discharged from the floating droplet nozzle 41 is sprayed to the user who operates the foot switch 7 from the injection hole 62 of the columnar sprayer 6 through the guide tube 5 and the guide pipe 61. The
Hereinafter, this content will be described in detail.
 本例の感染症防御システム1は図1に示すように、コンプレッサ2と、液体タンク3と、霧生成室4と、誘導チューブ5と、柱状噴霧器6と、足踏式スイッチ7とから構成される。
 また本システム1では人体や衣服に付着したウイルス汚染物の消毒用途として、抗菌作用を有する抗菌剤PRが用いられる。
As shown in FIG. 1, the infection prevention system 1 of this example includes a compressor 2, a liquid tank 3, a mist generation chamber 4, a guide tube 5, a column sprayer 6, and a foot switch 7. The
Further, in the present system 1, an antibacterial agent PR having an antibacterial action is used for disinfecting virus contaminants attached to a human body or clothes.
 抗菌剤PRは、細菌に対する抑制効果(抗菌効果・殺菌効果)やウイルスに対する不活化効果を有するものであって、人体に噴霧されるアミノ酸を含んだ液状の抗菌剤である。
 同抗菌剤PRは、植物性アミノ酸の一種である「大豆アミノ酸」由来の天然系有効成分を主成分として含んでいる。
 上記抗菌剤PRの効果を示す実験結果については、詳細な説明を後述する。
The antibacterial agent PR has an inhibitory effect on bacteria (antibacterial effect / bactericidal effect) and an inactivating effect on viruses, and is a liquid antibacterial agent containing amino acids sprayed on the human body.
The antibacterial agent PR contains as a main component a natural active ingredient derived from “soybean amino acid” which is a kind of vegetable amino acid.
A detailed description of the experimental results showing the effect of the antibacterial agent PR will be given later.
 図1に示す液体タンク3は、上述した抗菌剤PRを貯留する容器である。
 液体ストロー31(図2)は棒状の中空ストローであって、その排出口311を液体タンク3の外部に保持するとともに吸上口312が抗菌剤PRに浸るよう同タンク3に差込まれる。
The liquid tank 3 shown in FIG. 1 is a container that stores the antibacterial agent PR described above.
The liquid straw 31 (FIG. 2) is a rod-shaped hollow straw that is inserted into the tank 3 so that the discharge port 311 is held outside the liquid tank 3 and the suction port 312 is immersed in the antibacterial agent PR.
 図1に示すコンプレッサ2は、往復式(レシプロ式)・斜板式など任意のコンプレッサを利用できる。
 本例におけるコンプレッサ2はシリンダ22内をピストン23が往復運動するレシプロ式であり(図3参照)、ピストン23の往復運動によるシリンダ22の容積変化で圧縮する。
 同図3に示すようにコンプレッサ2のシリンダ22には、内向きのみに開く吸込弁25と、外向きのみに開く吐出弁26が取付けられている。
The compressor 2 shown in FIG. 1 can use any compressor such as a reciprocating type (reciprocating type) or a swash plate type.
The compressor 2 in this example is a reciprocating type in which the piston 23 reciprocates in the cylinder 22 (see FIG. 3), and compresses by changing the volume of the cylinder 22 due to the reciprocating motion of the piston 23.
As shown in FIG. 3, the cylinder 22 of the compressor 2 is provided with a suction valve 25 that opens only inward and a discharge valve 26 that opens only outward.
 ピストン23が同シリンダ22内部の容積を広げる向きに移動するとき、吸込弁25が開いて外部から空気がシリンダ22内に取込まれる。
 空気の取込後、ピストン23がシリンダ22内の容積を狭める向きに移動していくと空気は圧縮され、吐出弁26が開くことで圧縮された空気がシリンダ22外部へと排出される。
 本例では吐出弁26はエアチューブ27を介して空気ノズル28につながっているため、同ノズル28から圧縮された空気が噴射される。これによりコンプレッサ2により圧縮された空気が、空気ノズル28が挿入されている霧生成室4内部へと送り込まれる。
When the piston 23 moves in a direction to increase the volume inside the cylinder 22, the suction valve 25 is opened and air is taken into the cylinder 22 from the outside.
After the air has been taken in, the air is compressed when the piston 23 moves in a direction to reduce the volume in the cylinder 22, and the compressed air is discharged to the outside of the cylinder 22 by opening the discharge valve 26.
In this example, since the discharge valve 26 is connected to the air nozzle 28 via the air tube 27, compressed air is injected from the nozzle 28. Thereby, the air compressed by the compressor 2 is sent into the mist generation chamber 4 in which the air nozzle 28 is inserted.
 霧生成室4は、内部に閉空間を有する中空構造となっており、液体ストロー31の排出口311と空気ノズル28が差込まれている(図2)。
 さらに霧生成室4には、同閉空間に霧状に浮遊した抗菌剤PRを吐出する浮遊液滴ノズル41が取付けられている。
 浮遊液滴ノズル41は、霧生成室4内部(閉空間)に浮遊している霧状の抗菌剤PRを吐出する役割を果たす。
The mist generation chamber 4 has a hollow structure having a closed space inside, and the discharge port 311 and the air nozzle 28 of the liquid straw 31 are inserted (FIG. 2).
Furthermore, a floating droplet nozzle 41 that discharges the antibacterial agent PR suspended in a mist form in the same closed space is attached to the mist generation chamber 4.
The floating droplet nozzle 41 serves to discharge the mist-like antibacterial agent PR floating inside the mist generation chamber 4 (closed space).
 液体ストロー31により吸上げられた抗菌剤PRは、排出口311から霧生成室4中に霧状(微小液滴の状態)となって拡散する。
 さらに霧生成室4では空気ノズル28より吹込まれた圧縮空気が浮遊液滴ノズル41から排出されるため、同圧縮空気とともに霧状の抗菌剤PRも浮遊液滴ノズル41から霧生成室4の外部に吐出する。
The antibacterial agent PR sucked up by the liquid straw 31 is diffused in the mist generation state 4 from the discharge port 311 into the mist generation chamber 4.
Further, since the compressed air blown from the air nozzle 28 is discharged from the floating droplet nozzle 41 in the mist generation chamber 4, the mist-like antibacterial agent PR is also transferred from the floating droplet nozzle 41 to the outside of the mist generation chamber 4. To discharge.
 誘導チューブ5は図2に示すように、霧生成室4に取付けられた浮遊液滴ノズル41と、柱状噴霧器6の内部に格納されている誘導パイプ61とを連結することで、浮遊液滴ノズル41と誘導パイプ61を連通させる。 As shown in FIG. 2, the guide tube 5 connects the floating droplet nozzle 41 attached to the mist generation chamber 4 and the guide pipe 61 stored in the columnar sprayer 6, so that the floating droplet nozzle is connected. 41 and the guide pipe 61 are made to communicate.
 柱状噴霧器6は、噴射孔62の空いた誘導パイプ61を内部に格納するように構成された装置である(図2)。
 なおノロウイルスの大きさは27nm~37nmであることから、噴霧される抗菌剤PRの粒径20μm~30μm程度となるよう噴射孔62のノズル口径は「30μm」に形成されている。
 また本例では、抗菌剤PRの噴霧時間は「2秒」であり、1回あたりの抗菌剤PRの噴霧量は「20ml~40ml」である。
The columnar sprayer 6 is an apparatus configured to store the guide pipe 61 having the injection hole 62 therein (FIG. 2).
Since the size of the norovirus is 27 nm to 37 nm, the nozzle diameter of the injection hole 62 is set to “30 μm” so that the particle diameter of the sprayed antibacterial agent PR is about 20 μm to 30 μm.
In this example, the spray time of the antibacterial agent PR is “2 seconds”, and the spray amount of the antibacterial agent PR per one time is “20 ml to 40 ml”.
 また本感染症防御システム1では柱状噴霧器6を「2台以上」設置する。これらの柱状噴霧器6は立てた状態に設置して使用される。
 さらに本システム1は、トイレ利用者の人体・衣服に付着したウイルス汚染物に対して的確にかつ効率的に消毒を施せるよう「複数台の柱状噴霧器6の配置パターンにも工夫」がなされている。
 上述の柱状噴霧器6は、直線Lの両端ないしは多角形領域の各頂点に1台ずつ設置される(図8(a)、図8(b)、図8(c))。また柱状噴霧器6の抗菌剤噴射方向(噴射孔62のある面の向き)はすべて「直線Lの中点M・多角形領域の重心Gに向け」られる。
Further, in the infectious disease prevention system 1, “two or more” columnar sprayers 6 are installed. These columnar sprayers 6 are installed and used in an upright state.
Furthermore, the present system 1 is “devised in the arrangement pattern of the plurality of columnar sprayers 6” so that virus contaminants attached to the human body and clothes of the toilet user can be disinfected accurately and efficiently. .
One columnar sprayer 6 is installed at both ends of the straight line L or at each vertex of the polygonal region (FIGS. 8A, 8B, and 8C). Further, the antibacterial agent injection direction (direction of the surface having the injection holes 62) of the columnar sprayer 6 is all “directed toward the midpoint M of the straight line L and the center of gravity G of the polygonal region”.
 足踏式スイッチ7は、モメンタリ式(ボタンが押されて荷重が加わっている間だけオン状態になり、ボタンが荷重から解放されると自動復帰してオフ状態に戻る方式)のスイッチである。
 本例においては利用者の踏込操作により足踏式スイッチ7がオンになると(図4)、コンプレッサ2に電力が供給される。
 なお抗菌剤PRが本システム1の利用者に効率的に噴霧されるよう、同スイッチ7は直線Lの中点M・多角形領域の重心G付近に設置することが望ましい。
 また本説明例では円形の足踏式スイッチ7を採用しているが、同スイッチ7の形状は任意であり「矩形(例えば長方形)の平板型スイッチ」としてもよい。
 
The foot-operated switch 7 is a momentary switch (a system that is turned on only while the button is pressed and a load is applied, and automatically returns to the off state when the button is released from the load).
In this example, when the foot switch 7 is turned on by the user's stepping operation (FIG. 4), electric power is supplied to the compressor 2.
The switch 7 is preferably installed near the midpoint M of the straight line L and the center of gravity G of the polygonal region so that the antibacterial agent PR is efficiently sprayed to the user of the system 1.
In this example, a circular foot switch 7 is used. However, the shape of the switch 7 is arbitrary and may be a “rectangular (for example, rectangular) flat plate switch”.
 次に、本願発明において用いられる「抗菌剤PRの効果」について実験結果に基づき説明する。
 本例の抗菌剤PRは、大豆の抽出成分を抗菌成分として利用している。
 大豆には、人体に必要なアミノ酸のうち人の体内で合成することのできない必須アミノ酸であるトリプトファン・リシン・メチオニン・フェニルアラニン・トレオニン・バリン・ロイシン・イソロイシン・ヒスチジンが含まれている。
 さらに大豆には、人体に必要なアミノ酸のうち非必須アミノ酸に分類されるグリシン・アラニン・シスチン・セリン・アスパラギン・アスパラギン酸・グルタミン・グルタミン酸・アルギニン・チロシン・プロリンが含まれている。
Next, the “effect of the antibacterial agent PR” used in the present invention will be described based on experimental results.
The antibacterial agent PR of this example uses soybean extract components as antibacterial components.
Soybean contains tryptophan, lysine, methionine, phenylalanine, threonine, valine, leucine, isoleucine, and histidine, which are essential amino acids that cannot be synthesized in the human body among the amino acids necessary for the human body.
Furthermore, soybean contains glycine, alanine, cystine, serine, asparagine, aspartic acid, glutamine, glutamic acid, arginine, tyrosine, and proline, which are classified as non-essential amino acids among amino acids necessary for the human body.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 なお上記表1中にあるTCID50(TCID:median Tissue Culture Infectious Dose)はウイルス感染価の測定単位であり、あらかじめ細胞を培養して付着させた試験管などにウイルス希釈液を接種したときに50%の細胞に感染を及ぼす濃度をいう。
 また同表1中における菌量の単位は「CFU(Colony Forming Unit)/ml」であり、コロニーを形成する能力のある単位数(1ml中に存在する細菌の個数)を表す。
The TCID 50 (TCID: median Tissue Culture Infectious Dose) in Table 1 above is a unit for measuring the virus infectivity titer, and is 50 when the virus dilution is inoculated into a test tube or the like to which cells have been cultured and attached in advance. % Concentration that infects cells.
The unit of the amount of bacteria in Table 1 is “CFU (Colony Forming Unit) / ml”, which represents the number of units capable of forming colonies (the number of bacteria present in 1 ml).
 表1から看取されるように本抗菌剤PRは、ネコカリシウイルス(性質が類似するノロウイルスの代替)・SARSコロナウイルス・インフルエンザウイルスをはじめ「種々のウイルスに対する不活化効果」が有意に認められる。
 ノロウイルスは、非細菌性急性胃腸炎を引起こすウイルスである。
 またSARS(Severe Acute Respiratory Syndrome)コロナウイルスは、重症急性呼吸器症候群の病原体となるウイルスである。
 なおインフルエンザウイルスについては、H1N1株を使用して試験を実施した。
As can be seen from Table 1, this antibacterial agent PR has a significant “inactivation effect on various viruses” including feline calicivirus (substitute for norovirus with similar properties), SARS coronavirus, and influenza virus. .
Norovirus is a virus that causes non-bacterial acute gastroenteritis.
SARS (Severe Acute Respiratory Syndrome) coronavirus is a virus that is a pathogen of severe acute respiratory syndrome.
The influenza virus was tested using the H1N1 strain.
 また表1から看取されるように抗菌PRは、セレウス芽胞・黄色ブドウ球菌・腸管出血性大腸菌O-157・大腸菌・レジオネラ菌・サルモネラ菌をはじめ種々の「細菌類についても抗菌効果」が認められた。
 さらに本例の抗菌剤PRは表1から看取されるように、カビの繁殖を抑制する「抗カビ効果」を有することも確認されている。
As can be seen from Table 1, antibacterial PR has various antibacterial effects on bacteria including S. cerevisiae, Staphylococcus aureus, enterohemorrhagic Escherichia coli O-157, Escherichia coli, Legionella and Salmonella. It was.
Furthermore, as can be seen from Table 1, the antibacterial agent PR of this example has been confirmed to have an “antifungal effect” that suppresses the growth of mold.
 なおセレウス芽胞は、食中毒の原因となる菌であり腸管中の常在菌である。
 また黄色ブドウ球菌は、人の皮膚・消化管(腸)などに常在する菌であり表皮感染症・食中毒・肺炎・髄膜炎・敗血症などを引起こすおそれがある。
 腸管出血性大腸菌O-157は、加熱の不十分な食材から感染することの多い、出血性大腸炎を引起こす菌である。
 また大腸菌は、尿路感染症の原因菌にもなりうる。
 レジオネラ菌は、レジオネラ肺炎(在郷軍人病)をはじめとする多くのレジオネラ症を引起こす種を含んだ通性細胞内寄生性菌である。
 またサルモネラ菌は、腸チフス・パラチフスないしは感染型食中毒を引起こすものを含んだ腸内細菌である。
Cereus spores are bacteria that cause food poisoning and are resident bacteria in the intestinal tract.
Staphylococcus aureus is a bacterium that is resident in human skin, digestive tract (intestine), etc. and may cause epidermis infection, food poisoning, pneumonia, meningitis, sepsis, and the like.
Enterohemorrhagic Escherichia coli O-157 is a bacterium that causes hemorrhagic colitis that is often infected from foods that are not sufficiently heated.
E. coli can also be a causative agent of urinary tract infections.
Legionella is a facultative intracellular parasitic bacterium that contains many species that cause Legionella disease, including Legionella pneumonia (Military illness).
Salmonella is an enteric bacterium that includes typhoid, paratyphoid, or infectious food poisoning.
 ノロウイルス感染者の排泄物にはノロウイルスをはじめ様々なウイルスや細菌が潜んでいるため、トイレの利用者向けに感染症防止対策を打つことが望ましい。
 本例の感染症防御システムで使用される抗菌剤PRは、上述のようにウイルス不活化効果・抗菌効果が有意に認められるため「トイレ利用者の排泄物(ウイルス汚染物)に起因する感染症の拡大防止」に資する。
Since various viruses and bacteria including norovirus are lurking in the excrement of persons infected with norovirus, it is desirable to take measures to prevent infectious diseases for toilet users.
As described above, the antibacterial agent PR used in the infectious disease prevention system of this example has a significant virus inactivating effect and antibacterial effect, so that “infectious disease caused by toilet user excretion (viral contamination)” Contributing to the prevention of the spread of
 さらに上記成分はウイルス不活化作用や抗菌作用のみならず「消臭作用」も有している。
 腐敗とは、細菌などをはじめとする微生物により生物由来の有機物(特に、蛋白質などの窒素を含んだ有機物)が分解されることである。
 そして、いうまでもなく排泄物は、腐敗アミン(インドール、ケトンなど)の生成分解により不快臭(主に「アンモニア」や「硫化水素」による臭気)を放つ。
 しかしながら本抗菌剤PRは、図5(a)に示すように「アンモニア」に対しても、また図5(b)に示すように「硫化水素」に対しても優れた消臭効果を発揮することが実験により確認されている。
Furthermore, the above components have not only a virus inactivating action and an antibacterial action but also a “deodorizing action”.
Rotting means that organic matter derived from living organisms (particularly, organic matter containing nitrogen such as protein) is decomposed by microorganisms such as bacteria.
Needless to say, the excreta gives off unpleasant odors (mainly odors from “ammonia” and “hydrogen sulfide”) due to the formation and decomposition of spoiled amines (indoles, ketones, etc.).
However, the antibacterial agent PR exhibits an excellent deodorizing effect on “ammonia” as shown in FIG. 5A and also on “hydrogen sulfide” as shown in FIG. 5B. This has been confirmed by experiments.
 加えて本抗菌剤PRは、低級脂肪酸のうち畜産系不快臭の代表的成分をなす「イソ吉草酸」(図5(c))ならびに「ノルマル酪酸」(図5(d))に対しても優れた消臭効果を発揮する。
 上述した2種類の低級脂肪酸のうちイソ吉草酸については足裏部分の臭気として、またノルマル酪酸については口臭の一原因として人体に対する関連性を有する。
In addition, the antibacterial agent PR is also effective against “isovaleric acid” (FIG. 5 (c)) and “normal butyric acid” (FIG. 5 (d)), which are representative components of livestock unpleasant odor among lower fatty acids. Excellent deodorant effect.
Of the two types of lower fatty acids mentioned above, isovaleric acid has a relevance to the human body as a odor of the sole portion, and normal butyric acid has a cause of bad breath.
 さらに本抗菌剤PRが有する消臭効果は人に由来する臭気成分のみならず、魚類の腐敗臭気であるトリメチルアミン(魚類に含まれる浸透圧調節成分・トリメチルアミン-N-オキシドが還元されたもの)に対しても有効性を示した(図5(e)参照)。
 上記実験に使用したアンモニア・硫化水素・イソ吉草酸・ノルマル酪酸・トリメチルアミンはすべて悪臭防止法の規制対象物質に掲げられている。
Furthermore, the deodorizing effect of this antibacterial agent PR is not only due to odor components derived from humans, but also to trimethylamine (which is an osmotic pressure regulating component / trimethylamine-N-oxide contained in fish) that is a rotting odor of fish. The effectiveness was also shown (refer FIG.5 (e)).
Ammonia, hydrogen sulfide, isovaleric acid, normal butyric acid, and trimethylamine used in the experiment are all listed as substances subject to the Odor Control Law.
 なお大豆アミノ酸に由来するウイルス不活化有効成分や界面活性剤を溶液調整する際、活性水単体もしくは活性水にブチレングリコール(または2.7%のアルコール)を配合したものを希釈液として使用すればよい。
 このようにすることで抗菌剤PRの浸透性が高まり、ウイルス不活化効果・抗菌効果・消臭効果を効率的に発揮させることができる。
 
In addition, when preparing a virus inactivating active ingredient derived from soybean amino acid or a surfactant, a solution containing active water alone or a mixture of butylene glycol (or 2.7% alcohol) in active water is used as a diluent. Good.
By doing in this way, the permeability of the antibacterial agent PR is enhanced, and the virus inactivating effect, the antibacterial effect, and the deodorizing effect can be efficiently exhibited.
 次に、上記構成を備える感染症防御システム1の動作について説明する。
 図6に示すように足踏式スイッチ7に対する踏込動作が行われると、同スイッチ7がオンになり、コンプレッサ2に対して動作用の電力が供給される(ステップS1)。
Next, operation | movement of the infectious disease prevention system 1 provided with the said structure is demonstrated.
As shown in FIG. 6, when a stepping operation is performed on the foot switch 7, the switch 7 is turned on and electric power for operation is supplied to the compressor 2 (step S1).
 するとコンプレッサ2のモータ21(図3)が作動する。
 同コンプレッサ2においてシリンダ22中のピストン23が同シリンダ22内部の容積を広げる向きに移動すると、吸込弁25が内向きに開いて外部の空気がシリンダ22内に取込まれる(図6のステップS2)。
Then, the motor 21 (FIG. 3) of the compressor 2 operates.
In the compressor 2, when the piston 23 in the cylinder 22 moves in a direction to increase the volume inside the cylinder 22, the suction valve 25 opens inward and external air is taken into the cylinder 22 (step S2 in FIG. 6). ).
 空気の取込後、ピストン23によりシリンダ22内の容積を小さくしていくと同シリンダ22内の空気が圧縮され、吐出弁26が外向きに開くことで圧縮空気がシリンダ22外部へと排出される。
 本例では吐出弁26はエアチューブ27を介して空気ノズル28につながっているため(図2)、同ノズル28から圧縮された空気が噴射される(図6のステップS3)。するとコンプレッサ2により圧縮された空気が、空気ノズル28が挿入されている霧生成室4内部へと送り込まれる。
After the air is taken in, if the volume in the cylinder 22 is reduced by the piston 23, the air in the cylinder 22 is compressed, and the discharge valve 26 opens outward to discharge the compressed air to the outside of the cylinder 22. The
In this example, since the discharge valve 26 is connected to the air nozzle 28 through the air tube 27 (FIG. 2), compressed air is injected from the nozzle 28 (step S3 in FIG. 6). Then, the air compressed by the compressor 2 is sent into the mist generation chamber 4 in which the air nozzle 28 is inserted.
 この際、空気ノズル28と液体ストロー31の間に生じる負圧作用によって、液体タンク3中の抗菌剤PRが同ストロー31の吸上口312から排出口311に向かって吸上げられる(ステップS4)。
 吸上げられた抗菌剤PRは、排出口311から霧生成室4中に霧状(微小液滴の状態)となって拡散する。
At this time, the antibacterial agent PR in the liquid tank 3 is sucked up from the suction port 312 of the straw 31 toward the discharge port 311 by the negative pressure action generated between the air nozzle 28 and the liquid straw 31 (step S4). .
The sucked-up antibacterial agent PR diffuses in the form of mist (in the form of minute droplets) from the discharge port 311 into the mist generation chamber 4.
 さらに霧生成室4では空気ノズル28から吹込まれた圧縮空気が浮遊液滴ノズル41から排出される。
 そのため、同圧縮空気とともに霧状の抗菌剤PRも浮遊液滴ノズル41から霧生成室4の外部に吐出する(ステップS5)。
Further, in the fog generating chamber 4, the compressed air blown from the air nozzle 28 is discharged from the floating droplet nozzle 41.
Therefore, the mist-shaped antibacterial agent PR is also discharged from the floating droplet nozzle 41 to the outside of the mist generation chamber 4 together with the compressed air (step S5).
 そして誘導チューブ5と誘導パイプ61を介して、霧状の抗菌剤PRが柱状噴霧器6の噴射孔62から利用者に噴霧される(ステップS6)。
 なお抗菌剤PRは、利用者が着用している衣服の袖口、エプロン・前掛、ズボンの裾部分、靴などの履物にも噴霧される(図4)。
 以上で、トイレから利用者が退出するときに抗菌剤PRを噴霧することで、同利用者に付着したノロウイルス汚染物を効果的に消毒する一連の動作が終了する。
Then, the mist-like antibacterial agent PR is sprayed to the user from the injection hole 62 of the columnar sprayer 6 through the guide tube 5 and the guide pipe 61 (step S6).
The antibacterial agent PR is also sprayed on footwear such as cuffs, apron / front apron, trouser hem and shoes worn by the user (FIG. 4).
Thus, when the user leaves the toilet, the antibacterial agent PR is sprayed to complete a series of operations for effectively disinfecting norovirus contaminants attached to the user.
 以上説明したように本実施形態に係る感染症防御システムによれば、足踏式スイッチ7を取囲むように配置された柱状噴霧器6から抗菌剤PRが噴霧されることで、同抗菌剤PRがトイレから退出した利用者の下半身・腕・手などに効率的に浸透する。
 これにより「多人数で共用される施設・設備(とりわけトイレ)の使用者が同施設から退出するとき」にノロウイルスなどに起因する「感染症を効果的に防止」することができる。
 
As described above, according to the infection prevention system according to the present embodiment, the antibacterial agent PR is sprayed from the columnar sprayer 6 disposed so as to surround the foot switch 7 so that the antibacterial agent PR is It penetrates efficiently into the lower body, arms and hands of users who have left the toilet.
This makes it possible to “effectively prevent infectious diseases” caused by norovirus and the like when “users of facilities / equipment (especially toilets) shared by many people leave the facility”.
〔変形例:柱状噴霧器の配置パターン〕
 上記実施形態に係る感染症防御システムでは柱状噴霧器6の配置パターンとして、多角形領域の各頂点に柱状噴霧器6を1台ずつ設置することも可能である。
 図7(a)の例では三角形領域(同図7(a)の破線部)の3つの頂点に柱状噴霧器6を1台ずつ配置し、図7(b)の例では矩形領域(同図7(b)の破線部)の4つの頂点に柱状噴霧器6を1台ずつ配置している。
[Modification: Arrangement pattern of columnar sprayer]
In the infectious disease prevention system according to the above embodiment, as the arrangement pattern of the columnar sprayers 6, it is possible to install one columnar sprayer 6 at each vertex of the polygonal region.
In the example of FIG. 7A, one columnar sprayer 6 is arranged at three vertices of a triangular area (broken line portion of FIG. 7A), and in the example of FIG. One columnar sprayer 6 is disposed at each of the four apexes of the broken line portion (b).
 なお各柱状噴霧器6の抗菌剤噴射方向(噴射孔62の向き)を多角形領域の重心Gにすべて向けておくとともに、足踏式スイッチ7を重心G付近に設置することが望ましい(図8(b)、図8(c)参照)。
 このような構成を採用することで、足踏式スイッチ7の踏込操作を行うときに利用者が必然的に上述した重心G付近に位置することになるため、すべての柱状噴霧器6から抗菌剤PRが利用者に集中的に噴霧され、利用者に付着したウイルス汚染物に対する消毒効果の向上が図られるからである。
It should be noted that the antibacterial agent injection direction (direction of the injection hole 62) of each columnar sprayer 6 is all directed toward the center of gravity G of the polygonal region, and the foot switch 7 is preferably installed near the center of gravity G (FIG. 8 ( b), see FIG. 8C).
By adopting such a configuration, the user is inevitably positioned in the vicinity of the above-mentioned center of gravity G when the foot switch 7 is depressed, so that the antibacterial agent PR from all the columnar sprayers 6 is used. This is because the spray is concentrated on the user and the disinfection effect on the virus contaminants attached to the user is improved.
〔変形例:柱状噴霧器の囲い〕
 本感染症防御システムでは、隣合う柱状噴霧器6同士の間に板部材を立てることで囲いを構成してもよい(図9(a)、図9(b))。
 これにより、人体・衣服に噴霧された抗菌剤PRが柱状噴霧器6の周囲に飛散することを防止できる。
 また囲いを設けることで抗菌剤PRが囲いの中で滞留するため、抗菌剤PRが本システム利用者の全身にくまなく行き渡り、消毒効果が高まることも期待できる。
[Modification: Enclosure of column sprayer]
In this infectious disease prevention system, you may comprise an enclosure by standing a board member between adjacent columnar sprayers 6 (FIG. 9 (a), FIG.9 (b)).
Thereby, it is possible to prevent the antibacterial agent PR sprayed on the human body / clothes from being scattered around the columnar sprayer 6.
Moreover, since the antibacterial agent PR stays in the enclosure by providing the enclosure, it can be expected that the antibacterial agent PR spreads throughout the whole body of the user of the system and the disinfection effect is enhanced.
〔変形例:柱状噴霧器の柱形状〕
 本感染症防御システムでは、柱状噴霧器6の全体形状は直線形状に限定されず、L字形(図10参照)・コの字形など消毒効果を高めるための任意の形状を採用してもよい。
[Modification: Column shape of column sprayer]
In the present infection prevention system, the overall shape of the columnar sprayer 6 is not limited to a linear shape, and any shape for enhancing the disinfection effect such as an L shape (see FIG. 10) or a U shape may be adopted.
〔変形例:車輪付きの柱状噴霧器〕
 さらに本感染症防御システムでは、柱状噴霧器6の底面部分に車輪(いわゆるキャスタ)を設けてもよい。
 このようにすることで本システムの設置場所を変更する際に、運搬作業負担が大幅に軽減される。
 また本システムはトイレなどの多人数で共用する設備における利用を想定しているため、本システムそのものは勿論、本システムの設置されている場所(例えば床など)についても比較的汚れるのが早いと考えられる。
 そのような対処として定期的(例えば日次レベル)な清掃を行う場合にも柱状噴霧器6に車輪が設けられていれば、清掃開始時にいったん移動させておいた後、清掃完了後に柱状噴霧器6を元の位置に戻すときも労力を少なくできる。
 
[Modification: Columnar sprayer with wheels]
Furthermore, in this infection prevention system, you may provide a wheel (what is called a caster) in the bottom face part of the columnar sprayer 6. FIG.
In this way, when changing the installation location of the system, the burden of transportation work is greatly reduced.
In addition, since this system is intended for use in facilities that are shared by many people, such as toilets, the system itself, as well as the location where the system is installed (for example, the floor, etc.) can be relatively dirty. Conceivable.
If the columnar sprayer 6 is provided with wheels even when periodic (for example, daily level) cleaning is performed as such a countermeasure, the columnar sprayer 6 is moved once at the start of cleaning, and then the columnar sprayer 6 is moved after the cleaning is completed. The effort can be reduced when returning to the original position.
〔変形例:コンプレッサへの電力供給を制御するスイッチ方式〕
 本感染症防御システムでは、コンプレッサ2への電力供給を司るスイッチとして任意の方式のスイッチを採用することが可能である。
 しかしながらノロウイルスの感染拡大リスクを考慮して、本システムの利用者が「直接触れることなくオン・オフ操作を行えるスイッチ方式」が望ましい。
 このように利用者が非接触でオン・オフを操作できるスイッチとしては、上記実施形態において例示した足踏式スイッチ7に限らず「IC(Integrated Circuit)カードリーダ71と非接触型ICカード72」を採用することも可能である(図11)。
[Modification: Switch system for controlling power supply to the compressor]
In this infectious disease prevention system, it is possible to employ any type of switch as a switch that controls power supply to the compressor 2.
However, in consideration of the risk of spreading norovirus infection, it is desirable for the users of this system to be able to “switch on / off without touching directly”.
The switches that can be turned on and off by the user in a non-contact manner are not limited to the foot switch 7 illustrated in the above embodiment, but an “IC (Integrated Circuit) card reader 71 and a non-contact IC card 72”. It is also possible to adopt (FIG. 11).
 上記のICカードリーダ71を用いてコンプレッサ2への電力供給制御を行う場合、利用者が非接触型ICカード72をかざしてICカードリーダ71に近づけたときに、ICカードリーダ71と非接触型ICカード72の間で近距離無線通信を行う。
 そして同無線通信によりICカードリーダ71が非接触型ICカード72を検出したときに、ICカードリーダ71はコンプレッサ2のスイッチをオンする。
When power supply control to the compressor 2 is performed using the IC card reader 71, when the user holds the non-contact type IC card 72 close to the IC card reader 71, the IC card reader 71 and the non-contact type are controlled. Short-distance wireless communication is performed between the IC cards 72.
When the IC card reader 71 detects the non-contact type IC card 72 by the wireless communication, the IC card reader 71 turns on the switch of the compressor 2.
 なお図11のシステム構成を採用する場合、スイッチ部分については図1に示した構成(足踏式スイッチ7)と異なるものの、抗菌剤PRを噴霧する構成部分については同図1と同一の構成を踏襲すればよい。 When the system configuration shown in FIG. 11 is adopted, the switch portion is different from the configuration shown in FIG. 1 (the foot switch 7), but the configuration portion for spraying the antibacterial agent PR has the same configuration as FIG. Follow it.
 また同図11に示したシステム1Aの導入先が企業などの場合、「社員証を非接触型ICカード72で構成」しておき、社員1人1人を個々に識別可能とすることもできる。
 このようにすれば、ICカードリーダ71による非接触型ICカード72の読取履歴に基づいて「社員が、トイレの利用時に感染症防御システム1Aによる消毒を実施したかどうかの履歴」を電子データに記録することも可能になる。
 そのため従業員による「消毒実施について、より一層の周知徹底」が図られることを期待できる。
 
In addition, when the introduction destination of the system 1A shown in FIG. 11 is a company or the like, “employee ID is composed of a non-contact type IC card 72” can be used to identify each employee individually. .
In this way, based on the reading history of the non-contact type IC card 72 by the IC card reader 71, “history of whether or not the employee has performed disinfection by the infectious disease prevention system 1A when using the toilet” is converted into electronic data. It is also possible to record.
For this reason, it can be expected that employees will be able to further promote thorough awareness of disinfection.
〔変形例:抗菌成分〕
 本例の抗菌剤PRの抗菌有効成分は、大豆由来のアミノ酸に限らず、タンパク質の構成成分となるアミノ酸であるグリシン・システイン、または、グリシンの2分子がペプチド結合したグリシルグリシンなど、ウイルス不活化作用のある任意の植物性または動物性由来のアミノ酸を採用することも可能である。
 なお抗菌剤PRそのものは、この抗菌有効成分に界面活性剤を配合して調製する。
 またグリシン・システイン・グリシルグリシンは強い消臭作用も併せ持つため、トイレの利用者にノロウイルスなどが混じった汚物(糞便や嘔吐物)が付着している場合でも、これらの汚物から放たれる臭気を抑制することができる。
[Modification: Antibacterial component]
The antibacterial active ingredient of the antibacterial agent PR of this example is not limited to amino acids derived from soybeans, but is not virus-free, such as glycine cysteine, which is an amino acid that constitutes a protein component, or glycylglycine in which two molecules of glycine are peptide-bonded. Any plant- or animal-derived amino acid having an activating effect may be employed.
The antibacterial agent PR itself is prepared by blending a surfactant with this antibacterial active ingredient.
Glycine, cysteine, and glycylglycine also have a strong deodorizing effect, so even if the toilet user is attached with filth (feces or vomit) mixed with norovirus, the odor emitted from these filth Can be suppressed.
 以上、実施形態を参照して本発明を説明したが、本発明は上記実施形態に限定されるものではない。本発明の構成や詳細には、本発明の要旨を逸脱しない範囲で当業者が理解し得る各種の変形が可能である。 The present invention has been described above with reference to the embodiments, but the present invention is not limited to the above embodiments. Various modifications that can be understood by those skilled in the art can be made to the configuration and details of the present invention without departing from the gist of the present invention.
 1 感染症防御システム
 2 コンプレッサ
 21 モータ
 22 シリンダ
 23 ピストン
 24 ピストンロッド
 25 空気吸入弁
 26 空気排出弁
 27 エアチューブ
 28 空気ノズル
 3 液体タンク
 31 液体ストロー
 311 排出口
 312 吸上口
 4 霧生成室
 41 浮遊液滴ノズル
 5 誘導チューブ
 6 柱状噴霧器
 61 誘導パイプ
 62 噴射孔
 7 足踏式スイッチ
 71 ICカードリーダ
 72 ICカード
 PR 抗菌剤
DESCRIPTION OF SYMBOLS 1 Infectious disease prevention system 2 Compressor 21 Motor 22 Cylinder 23 Piston 24 Piston rod 25 Air suction valve 26 Air discharge valve 27 Air tube 28 Air nozzle 3 Liquid tank 31 Liquid straw 311 Discharge port 312 Suction port 4 Fog generation chamber 41 Floating liquid Drop nozzle 5 Induction tube 6 Column sprayer 61 Induction pipe 62 Injection hole 7 Foot switch 71 IC card reader 72 IC card PR Antibacterial agent

Claims (4)

  1.  直線の両端部または多角形領域の各頂点に2台以上の柱状噴霧器を立てた状態で配置するとともに、同柱状噴霧器の噴射孔のある面を前記直線の中点または前記多角形領域の重心に向けて設置し、穀物から抽出したアミノ酸を含む抗菌剤を各柱状噴霧器の噴射孔から同時に噴霧することで人体を消毒する感染症防御システムであって、
     
     前記抗菌剤を貯留する液体タンクと、
     棒状の中空ストローであって、その排出口を前記液体タンクの外部に保持するとともに吸上口が抗菌剤に浸るよう同液体タンクに差込まれる液体ストローと、
     外部から取込んだ空気を圧縮して空気ノズルから噴射するコンプレッサと、
     前記空気ノズルならびに液体ストローの排出口が差込まれた閉空間を成し、かつ同閉空間に霧状に浮遊した抗菌剤を吐出する浮遊液滴ノズルが取付けられた霧生成室と、
     前記噴射孔の空いた誘導パイプを内部に格納して成る2台以上の前記柱状噴霧器と、
     前記霧生成室の浮遊液滴ノズルと前記柱状噴霧器内部の誘導パイプとを連結する誘導チューブと、
     前記コンプレッサへの電力供給を司るスイッチであって、利用者の踏込操作により荷重がかかるとオンになり同荷重から解放されるとオフになる足踏式スイッチと、
     を備え、
     
     前記柱状噴霧器に挟まれた直線上または柱状噴霧器に囲まれた多角形領域内に置かれた足踏式スイッチが利用者の踏込操作でオンになり、コンプレッサに電力が供給された場合、
     前記空気ノズルから空気が噴射されたことで霧生成室に生じた負圧により、液体ストローから同霧生成室に抗菌剤が吸上げられるとともに霧状の同抗菌剤が浮遊液滴ノズルから吐出され、
     同浮遊液滴ノズルから吐出された抗菌剤が誘導チューブと誘導パイプを介して前記柱状噴霧器の噴射孔から前記足踏式スイッチを操作した利用者に噴霧される
     ように構成されたことを特徴とする、感染症防御システム。
     
    Two or more columnar sprayers are placed upright at both ends of the straight line or at each vertex of the polygonal region, and the surface with the injection holes of the columnar sprayer is set at the midpoint of the straight line or the center of gravity of the polygonal region An infectious disease prevention system that disinfects the human body by spraying antibacterial agents containing amino acids extracted from cereals simultaneously from the spray holes of each columnar sprayer,

    A liquid tank for storing the antibacterial agent;
    A rod-shaped hollow straw that holds the discharge port outside the liquid tank and is inserted into the liquid tank so that the suction port is immersed in the antibacterial agent;
    A compressor that compresses air taken from outside and injects it from an air nozzle;
    A mist generation chamber in which a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, and a floating droplet nozzle that discharges the antibacterial agent suspended in a mist form in the closed space, is attached;
    Two or more columnar sprayers configured to house the guide pipe with the injection hole therein;
    A guide tube connecting the floating droplet nozzle of the fog generating chamber and a guide pipe inside the columnar sprayer;
    A switch for controlling power supply to the compressor, and is a foot switch that is turned on when a load is applied by a user's stepping operation and turned off when released from the load;
    With

    When a foot switch placed on a straight line sandwiched between the columnar sprayers or in a polygonal region surrounded by the columnar sprayers is turned on by the user's stepping operation and power is supplied to the compressor,
    The antibacterial agent is sucked up from the liquid straw into the mist generation chamber by the negative pressure generated in the mist generation chamber by the air being jetted from the air nozzle, and the mist-like antibacterial agent is discharged from the floating droplet nozzle. ,
    The antibacterial agent discharged from the floating droplet nozzle is sprayed from a spray hole of the columnar sprayer to a user who operates the foot switch via a guide tube and a guide pipe. Infectious disease protection system.
  2.  直線の両端部または多角形領域の各頂点に2台以上の柱状噴霧器を立てた状態で配置するとともに、同柱状噴霧器の噴射孔のある面を前記直線の中点または前記多角形領域の重心に向けて設置し、穀物から抽出したアミノ酸を含む抗菌剤を各柱状噴霧器の噴射孔から同時に噴霧することで人体を消毒する感染症防御システムであって、
     
     前記抗菌剤を貯留する液体タンクと、
     棒状の中空ストローであって、その排出口を前記液体タンクの外部に保持するとともに吸上口が抗菌剤に浸るよう同液体タンクに差込まれる液体ストローと、
     外部から取込んだ空気を圧縮して空気ノズルから噴射するコンプレッサと、
     前記空気ノズルならびに液体ストローの排出口が差込まれた閉空間を成し、かつ同閉空間に霧状に浮遊した抗菌剤を吐出する浮遊液滴ノズルが取付けられた霧生成室と、
     前記噴射孔の空いた誘導パイプを内部に格納して成る2台以上の前記柱状噴霧器と、
     前記霧生成室の浮遊液滴ノズルと前記柱状噴霧器内部の誘導パイプとを連結する誘導チューブと、
     当該感染症防御システムの利用者が所持する非接触型IC(Integrated Circuit)カードと、
     前記コンプレッサへの電力供給を司る装置であって、利用者によってかざされた非接触型ICカードを検出したときにコンプレッサをオンにするICカードリーダと、
     を備え、
     
     前記柱状噴霧器に挟まれた直線上または柱状噴霧器に囲まれた多角形領域内に置かれたICカードリーダが利用者によりかざされた非接触型ICカードを検出することでコンプレッサのスイッチがオンになり、コンプレッサに電力が供給された場合、
     前記空気ノズルから空気が噴射されたことで霧生成室に生じた負圧により、液体ストローから同霧生成室に抗菌剤が吸上げられるとともに霧状の同抗菌剤が浮遊液滴ノズルから吐出され、
     同浮遊液滴ノズルから吐出された抗菌剤が誘導チューブと誘導パイプを介して前記柱状噴霧器の噴射孔から前記足踏式スイッチを操作した利用者に噴霧される
     ように構成されたことを特徴とする、感染症防御システム。
     
    Two or more columnar sprayers are placed upright at both ends of the straight line or at each vertex of the polygonal region, and the surface with the injection holes of the columnar sprayer is set at the midpoint of the straight line or the center of gravity of the polygonal region An infectious disease prevention system that disinfects the human body by spraying antibacterial agents containing amino acids extracted from cereals simultaneously from the spray holes of each columnar sprayer,

    A liquid tank for storing the antibacterial agent;
    A rod-shaped hollow straw that holds the discharge port outside the liquid tank and is inserted into the liquid tank so that the suction port is immersed in the antibacterial agent;
    A compressor that compresses air taken from outside and injects it from an air nozzle;
    A mist generation chamber in which a closed space into which the air nozzle and the discharge port of the liquid straw are inserted, and a floating droplet nozzle that discharges the antibacterial agent suspended in a mist form in the closed space, is attached;
    Two or more columnar sprayers configured to house the guide pipe with the injection hole therein;
    A guide tube connecting the floating droplet nozzle of the fog generating chamber and a guide pipe inside the columnar sprayer;
    A contactless IC (Integrated Circuit) card possessed by the user of the infectious disease prevention system;
    An apparatus that controls power supply to the compressor, and an IC card reader that turns on the compressor when a non-contact IC card held by a user is detected;
    With

    When the IC card reader placed on a straight line sandwiched between the columnar sprayers or in a polygonal region surrounded by the columnar sprayers detects a non-contact IC card held by the user, the compressor is turned on. When power is supplied to the compressor,
    The antibacterial agent is sucked up from the liquid straw into the mist generation chamber by the negative pressure generated in the mist generation chamber by the air being jetted from the air nozzle, and the mist-like antibacterial agent is discharged from the floating droplet nozzle. ,
    The antibacterial agent discharged from the floating droplet nozzle is sprayed from a spray hole of the columnar sprayer to a user who operates the foot switch via a guide tube and a guide pipe. Infectious disease protection system.
  3.  請求項1または2に記載の感染症防御システムであって、
     前記柱状噴霧器は、立てて配置したときの高さが1m以上である
     ように構成されたことを特徴とする、感染症防御システム。
     
    The infectious disease prevention system according to claim 1 or 2,
    The columnar sprayer is configured to have a height of 1 m or more when placed upright, and an infectious disease protection system.
  4.  穀物から抽出されたアミノ酸をそれぞれに含んで成る抗菌剤であって、
     
     加熱処理ならびに濾過処理がなされた後に凝集剤が添加された穀物の溶液から固形物を分離することで抽出されるアミノ酸混合液であって、大豆抽出アミノ酸を含んだアミノ酸混合液と、
     精製水ならびにpH値が12である特殊還元性アルカリイオン水と、
     ブチレングリコールと、
     陽イオン界面活性剤と、
     両性イオン界面活性剤と、
     非イオン系界面活性剤と、
     キレート剤と、
     を有するように構成されたことを特徴とする、抗菌剤。
    An antibacterial agent comprising amino acids extracted from cereals,

    An amino acid mixed solution extracted by separating a solid from a grain solution to which a flocculant has been added after heat treatment and filtration treatment, and an amino acid mixed solution containing a soybean extracted amino acid;
    Purified water and special reducing alkaline ionized water having a pH value of 12,
    Butylene glycol,
    A cationic surfactant,
    A zwitterionic surfactant,
    A nonionic surfactant,
    Chelating agents,
    An antibacterial agent characterized by comprising the following.
PCT/JP2016/074303 2015-10-15 2016-08-20 System for defending against infection, and antimicrobial agent WO2017064923A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015203313A JP2017074211A (en) 2015-10-15 2015-10-15 Infection disease protection system and antibacterial agent
JP2015-203313 2015-10-15

Publications (1)

Publication Number Publication Date
WO2017064923A1 true WO2017064923A1 (en) 2017-04-20

Family

ID=58517480

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/074303 WO2017064923A1 (en) 2015-10-15 2016-08-20 System for defending against infection, and antimicrobial agent

Country Status (2)

Country Link
JP (1) JP2017074211A (en)
WO (1) WO2017064923A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210370034A1 (en) * 2020-05-27 2021-12-02 Craig Crippen Decontamination Station
JP7046142B1 (en) 2020-10-27 2022-04-01 株式会社ジーエイト New coronavirus countermeasure sterilization device

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6836272B2 (en) * 2017-09-26 2021-02-24 株式会社アクト Disinfection device
JP7026720B2 (en) * 2020-04-24 2022-02-28 義幸 ▲高▼部 Human body disinfection device
AU2021361366A1 (en) * 2020-10-13 2023-03-02 Panasonic Intellectual Property Management Co., Ltd. Chemical spraying system and method for operating same
CN114053463B (en) * 2021-11-25 2023-04-11 浙江百世技术有限公司 Commodity circulation packing box degassing unit

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06142168A (en) * 1992-11-09 1994-05-24 Sunstar Inc Composition of sterilizing deodorant
JPH08175905A (en) * 1994-12-27 1996-07-09 Kyowa Hakko Kogyo Co Ltd Antimicrobial deodorant
JPH1063178A (en) * 1996-08-14 1998-03-06 Omron Corp Operation device
JP2003135580A (en) * 2001-10-30 2003-05-13 Id Systems:Kk Deodorizing gate
JP2009261596A (en) * 2008-04-24 2009-11-12 Keiyu:Kk Sterilization system unit of doorway and passage of isolation ward
JP2010063762A (en) * 2008-09-12 2010-03-25 Yoshiharu Masui Antibacterial deodorant
JP2011094413A (en) * 2009-10-30 2011-05-12 Fuji Electric Retail Systems Co Ltd Washing device
JP2011256301A (en) * 2010-06-10 2011-12-22 Kao Corp Skin bactericidal detergent composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4446490B1 (en) * 2009-09-28 2010-04-07 メトラス株式会社 Purification device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06142168A (en) * 1992-11-09 1994-05-24 Sunstar Inc Composition of sterilizing deodorant
JPH08175905A (en) * 1994-12-27 1996-07-09 Kyowa Hakko Kogyo Co Ltd Antimicrobial deodorant
JPH1063178A (en) * 1996-08-14 1998-03-06 Omron Corp Operation device
JP2003135580A (en) * 2001-10-30 2003-05-13 Id Systems:Kk Deodorizing gate
JP2009261596A (en) * 2008-04-24 2009-11-12 Keiyu:Kk Sterilization system unit of doorway and passage of isolation ward
JP2010063762A (en) * 2008-09-12 2010-03-25 Yoshiharu Masui Antibacterial deodorant
JP2011094413A (en) * 2009-10-30 2011-05-12 Fuji Electric Retail Systems Co Ltd Washing device
JP2011256301A (en) * 2010-06-10 2011-12-22 Kao Corp Skin bactericidal detergent composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210370034A1 (en) * 2020-05-27 2021-12-02 Craig Crippen Decontamination Station
JP7046142B1 (en) 2020-10-27 2022-04-01 株式会社ジーエイト New coronavirus countermeasure sterilization device
JP2022070317A (en) * 2020-10-27 2022-05-13 株式会社ジーエイト Sterilization device for novel coronavirus

Also Published As

Publication number Publication date
JP2017074211A (en) 2017-04-20

Similar Documents

Publication Publication Date Title
WO2017064923A1 (en) System for defending against infection, and antimicrobial agent
CN108025182B (en) Method and device for disinfection, sterilization and disinfection
CN108136139A (en) For the system and method for disinfecting surface
JP5866743B1 (en) Clothes disinfection device and clothes disinfection method
JP5547433B2 (en) Ion sterilization air discharger
CN103493847B (en) Environment-friendly immersing and spraying liquid and preparation method thereof
JP2011019857A5 (en)
WO2009114962A1 (en) A molecule state air disinfecting cleaner
CN101006790A (en) Refined iodine disinfectant liquor
KR100744707B1 (en) One disinfection room made of combination sterilization room
KR20130027815A (en) Hand sterilizer
JP4795927B2 (en) Sterilization air purifier for health
KR20070119970A (en) Functional lotion including nano silver
CN205515679U (en) Disinfect and remove peculiar smell spray disinfection system
JP2020089566A (en) Wet sheet
KR20120050886A (en) Mobile Cleanroom Sterilizer
Sojitra et al. Saltwater as a Disinfectant and Cleaning agent for Environmental Surfaces in the context of SARS-COV-II.
CN211132315U (en) Non-alcohol atomization disinfection system
US20210370034A1 (en) Decontamination Station
KR101674788B1 (en) Footwear sterilizer and deodorizer
KR100321411B1 (en) Disinfectant sanitary tissue
CN110721326A (en) Manufacturing and application of multifunctional laboratory disinfection cleaning machine
KR200385204Y1 (en) The entrance fragrance spray by wireless system
US11622930B2 (en) Antimicrobial agent
Tierno Jr First, Wear a Face Mask: A Doctor's Guide to Reducing Risk of Infection During the Pandemic and Beyond

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16855177

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16855177

Country of ref document: EP

Kind code of ref document: A1